ELICITYL总部位于法国格勒诺布尔,是一家致力于复杂糖类工程和生产的生物技术公司。该公司的任务是针对植物健康,药学,营养保健品和化妆品为生物应用提供寡糖和多糖。
elicityl-oligotech | GLY120-BSA | Globotriaose (Gb3) / Pk antigen linked to BSA | 1mg | 14305.5 |
elicityl-oligotech | GLY121-BSA | Globotetraose (Gb4) / P antigen linked to BSA | 1mg | 14305.5 |
elicityl-oligotech | GLY124-BSA | Globo-A heptaose linked to BSA | 1mg | 14305.5 |
elicityl-oligotech | GLY125-BSA | Globo-B heptaose linked to BSA | 1mg | 14305.5 |
elicityl-oligotech | GLY131-BSA | SSEA-4 hexaose - BSA | 1mg | 14305.5 |
elicityl-oligotech | GLY132-BSA | Forssman antigen pentaose linked to BSA | 1mg | 14305.5 |
elicityl-oligotech | GLY134-BSA | Isoforssman antigen pentaose linked to BSA | 1mg | 14305.5 |
elicityl-oligotech | GLY089-95% | 2,6'-Sialyllactose (6'SL) (95% NMR) | 1000mg | 14305.5 |
elicityl-oligotech | GLU329-90% | Maltopentadecaose DP15 (>90% HPLC) | 25mg | 14305.5 |
elicityl-oligotech | GLU329-85% | Maltopentadecaose DP15 (>85% HPLC) | 25mg | 14305.5 |
elicityl-oligotech | GLY070-90% | copy of Isoglobotriaose / iGb3 / 3'-Galactosyl-lactose/ linear B-6 trisaccharide (>90% NMR) | 100mg | 14305.5 |
elicityl-oligotech | GLY070-90% | copy of Isoglobotriaose / iGb3 / 3'-Galactosyl-lactose/ linear B-6 trisaccharide (>90% NMR) | 100mg | 14305.5 |
elicityl-oligotech | GLU319-98% | Maltononaose DP9 (>98% HPLC) | 25mg | 14399 |
elicityl-oligotech | GLU319-99% | Maltononaose DP9 (>99% HPLC) | 25mg | 14399 |
elicityl-oligotech | GLY081-85% | LS-Tetrasaccharide a (LSTa) / Sialyl-lacto-N-tetraose a (>85% NMR) (Sodium salt) | 25mg | 14679.5 |
elicityl-oligotech | GAT101 | Galacturonan polysaccharides HM from apple (sodium salt) | 10000mg | 14773 |
elicityl-oligotech | GAT103 | Galacturonan polysaccharides HM from citrus (sodium salt) | 10000mg | 14773 |
elicityl-oligotech | GLY035-3-95% | Blood group A antigen tetraose type 5 (>95% NMR) | 25mg | 14773 |
elicityl-oligotech | GLY046-75% | Lewis a (Lea) triaose | 25mg | 14773 |
elicityl-oligotech | GLY048-90% | Lewis Y (LeY) tetraose (>90% NMR) | 25mg | 14773 |
elicityl-oligotech | GLU306-90% | Cellooctaose (>90% HPAEC-PAD) | 10mg | 14866.5 |
elicityl-oligotech | GLY023-95% | Lacto-N-neooctaose (LNnO) (>95% HPLC) | 5mg | 14866.5 |
elicityl-oligotech | GLY049-90% | Lewis x (LeX) triaose /SSEA-1 / CD15 (>90% NMR) | 25mg | 14866.5 |
elicityl-oligotech | FRU117-90% | Fructo-oligosaccharide DP11 / GF10 (>90% HPAEC-PAD) | 10mg | 14960 |
elicityl-oligotech | ALG342 | Guluronate oligosaccharides DP2 (sodium salt) | 25mg | 16082 |
elicityl-oligotech | ALG343 | Guluronate oligosaccharides DP3 (sodium salt) | 25mg | 16082 |
elicityl-oligotech | ALG344 | Guluronate oligosaccharides DP4 (sodium salt) | 25mg | 16082 |
elicityl-oligotech | GLY031-3-98% | Blood group H antigen triaose type 5 / 2’Fucosyllactose / 2'FL (>98% HPLC) | 100mg | 15053.5 |
elicityl-oligotech | GLY071-95% | Galili antigen pentaose (>95% NMR) | 5mg | 15053.5 |
elicityl-oligotech | FRU111-95% | Fructo-oligosaccharide DP5 /GF4 / Fructofuranosyl-Nystose (>95% HPAEC-PAD) | 75mg | 15147 |
elicityl-oligotech | GLY070-95% | Isoglobotriaose / iGb3 / 3'-Galactosyl-lactose/ linear B-6 trisaccharide (>95% NMR) | 100mg | 15334 |
elicityl-oligotech | GLY031-3-99% | Blood group H antigen triaose type 5 / 2’Fucosyllactose / 2'FL (>99% HPLC) | 75mg | 15427.5 |
elicityl-oligotech | REF010 | Lacto-N-tetraose (LNT) Analytical Reference | 10mg | 15427.5 |
elicityl-oligotech | REF031-3 | 2’Fucosyllactose (2'FL) Analytical Reference | 10mg | 15427.5 |
elicityl-oligotech | FRU118-70% | Fructo-oligosaccharide DP12 / GF11 (>70% HPAEC-PAD) | 50mg | 15614.5 |
elicityl-oligotech | GLY010-90% | Lacto-N-tetraose (LNT) (>90% NMR) | 50mg | 15708 |
elicityl-oligotech | GLY078-90% | Galili antigen nonaose (>90% NMR) | 5mg | 15801.5 |
elicityl-oligotech | GAT200 | Apiogalacturonan polysaccharide (sodium salt) | 100mg | 15988.5 |
elicityl-oligotech | GLU1141 | Reduced XLLG oligosaccharide (XLLGol) | 100mg | 15988.5 |
elicityl-oligotech | GLU302-90% | Cellotetraose (>90% HPAEC-PAD) | 100mg | 15988.5 |
elicityl-oligotech | HGL200 | Glucurono-XyloMannan polysaccharide from Tremella fuciformis | 100mg | 15988.5 |
elicityl-oligotech | GLY096-90% | GM1a Ganglioside oligosaccharide (>90%) (Sodium salt) | 25mg | 17204 |
elicityl-oligotech | GLY023-98% | Lacto-N-neooctaose (LNnO) (>98% HPLC) | 5mg | 16269 |
elicityl-oligotech | GLY045-90% | Lewis b (Leb) tetraose (>90% NMR) | 25mg | 16269 |
elicityl-oligotech | GLY074-2-90% | Xeno antigen type 2 / Galili antigen triaose / Galα -3 epitope/Linear B-2 trisaccharide (>90% NMR) | 25mg | 16362.5 |
elicityl-oligotech | GLY153-NPR | Galα1-3Gal-N-Acetyl-Propargyl | 25mg | 16362.5 |
elicityl-oligotech | GLU320-99% | Maltodecaose DP10 (>99% HPLC) | 25mg | 16456 |
elicityl-oligotech | GLY021-95% | Lacto-N-neotetraose (LNnT / neo-LNT) (>95% HPLC) | 50mg | 16456 |
elicityl-oligotech | GLU310 | Maltodextrin High DP10-40 oligosaccharide mixture | 1000mg | 16549.5 |
elicityl-oligotech | GLU311 | Maltodextrin oligosaccharide mixture | 1000mg | 16549.5 |
elicityl-oligotech | GLU319-90% | Maltononaose DP9 (>90% HPLC) | 500mg | 16549.5 |
elicityl-oligotech | GLY070-98% | Isoglobotriaose / iGb3 / 3'-Galactosyl-lactose/ linear B-6 trisaccharide (>98% NMR) | 100mg | 16643 |
elicityl-oligotech | GLY046-85% | Lewis a (Lea) triaose | 25mg | 16923.5 |
elicityl-oligotech | GLY060-90% | 3 Fucosyllactose / 3-FL (>90% NMR) | 100mg | 17017 |
elicityl-oligotech | FRU116-90% | Fructo-oligosaccharide DP10 / GF9 (>90% HPAEC-PAD) | 25mg | 17110.5 |
elicityl-oligotech | GLU306-95% | Cellooctaose (>95% HPAEC-PAD) | 10mg | 17110.5 |
elicityl-oligotech | GLY031-3-99% | Blood group H antigen triaose type 5 / 2’Fucosyllactose / 2'FL (>99% HPLC) | 100mg | 17110.5 |
elicityl-oligotech | GLY052-90% | Lewis y (LeY) pentaose (>90% NMR) | 25mg | 17204 |
elicityl-oligotech | GLY054-90% | Lewis a (Lea) tetraose (>90% NMR) | 25mg | 17204 |
elicityl-oligotech | GLY056-90% | Lewis b (Le b) pentaose (>90% NMR) | 25mg | 17204 |
elicityl-oligotech | GLY081-90% | LS-Tetrasaccharide a (LSTa) / Sialyl-lacto-N-tetraose a (>90% NMR) (Sodium salt) | 25mg | 17204 |
elicityl-oligotech | GLY083-90% | LS-Tetrasaccharide d (LSTd) / Sialyl-lacto-N-neotetraose d (>90% NMR) (Sodium salt) | 25mg | 17204 |
elicityl-oligotech | GLY104-90% | aGM2 (asialo GM2) Ganglioside oligosaccharide / GA2 (>90% NMR) (Sodium salt) | 25mg | 17204 |
elicityl-oligotech | GLY122-90% | Globopentaose (Gb5) / Stage Specific Embryonic Antigen 3a (SSEA-3a) (>90% NMR) | 25mg | 17204 |
elicityl-oligotech | GLY151-95% | GalNAcβ1-3Gal / Gb4 Globoside terminal | 25mg | 17204 |
elicityl-oligotech | GLU440-1 | Chitin-Oligosaccharides kit from DP 2 to DP 7 | 10mg | 17297.5 |
elicityl-oligotech | FRU112-90% | Fructo-oligosaccharide DP6 / GF5 / 1-F-(1-β-fructofuranosyl)-2-nystose (>90% HPAEC-PAD) | 50mg | 17391 |
elicityl-oligotech | GLY033-2-NPR | Blood group H antigen pentaose type 2-NAc-propargyl | 1mg | 17391 |
elicityl-oligotech | GLY129-85% | Blood group B antigen pentasaccharide type 4 (>85% NMR) | 25mg | 17391 |
elicityl-oligotech | ALG542 | Manuronate oligosaccharide DP2 (sodium salt) | 25mg | 17484.5 |
elicityl-oligotech | ALG543 | Manuronate oligosaccharide DP3 (sodium salt) | 25mg | 17484.5 |
elicityl-oligotech | ALG544 | Manuronate oligosaccharide DP4 (sodium salt) | 25mg | 17484.5 |
elicityl-oligotech | GLY071-GEL | Galili antigen pentaose linked to gel matrix 1 ml | 1mg | 17484.5 |
elicityl-oligotech | GLU436-90% | Chitin oligosaccharides DP6 / chitinhexaose (>90% RMN) | 50mg | 17671.5 |
elicityl-oligotech | GLY079-90% | Galili antigen undecaose (>90% NMR) | 5mg | 17858.5 |
elicityl-oligotech | GLY096-OAP | GM1a Ganglioside oligosaccharide-β-aminopropyl (>90%) (Sodium salt) | 1mg | 19167.5 |
elicityl-oligotech | GLY100-NPR | GT1a Ganglioside oligosaccharide-NAc-propargyl (Sodium salt) | 1mg | 19167.5 |
elicityl-oligotech | GLY096-NPR | GM1a Ganglioside oligosaccharide-β-N-Acetyl Propargyl (Sodium salt) | 5mg | 19167.5 |
elicityl-oligotech | GLY093-NPR | GM2 Ganglioside oligosaccharide-NAc-propargyl | 1mg | 19167.5 |
elicityl-oligotech | GLY092-NPR | GT3 Ganglioside oligosaccharide-NAc-propargyl (Sodium salt) | 1mg | 19167.5 |
elicityl-oligotech | GLY098-NPR | GD1a Ganglioside oligosaccharide-β-NAc-propargyl (Sodium salt) | 1mg | 19167.5 |
elicityl-oligotech | GLY094-NPR | GD2 Ganglioside oligosaccharide-β-NAc-propargyl | 1mg | 19167.5 |
elicityl-oligotech | GLY047-90% | Sialyl LewisX (sLeX) tetraose (>90% NMR) | 25mg | 17952 |
elicityl-oligotech | GLY047-80% | Sialyl LewisX (sLeX) tetraose (>80% NMR) | 25mg | 17952 |
elicityl-oligotech | GLU411 | Colloidal Chitin polysaccharide | 10000mg | 18045.5 |
elicityl-oligotech | GLU320-90% | Maltodecaose DP10 (>90% HPLC) | 500mg | 18232.5 |
elicityl-oligotech | GLY032-1-70% | Blood group H antigen tetraose type 1 (>70% NMR) | 25mg | 18232.5 |
elicityl-oligotech | ALG500 | Mannuronate oligosaccharides Average DP20 (sodium salt) | 1000mg | 19541.5 |
elicityl-oligotech | FRU111-95% | Fructo-oligosaccharide DP5 /GF4 / Fructofuranosyl-Nystose (>95% HPAEC-PAD) | 100mg | 18419.5 |
elicityl-oligotech | GLU302-95% | Cellotetraose (>95% HPAEC-PAD) | 100mg | 18419.5 |
elicityl-oligotech | GAT114 | Galacturonan oligosaccharides Mixture DP10/DP15 | 250mg | 18513 |
elicityl-oligotech | ALG310 | Guluronate oligosaccharides average DP10 (sodium salt) | 100mg | 19915.5 |
elicityl-oligotech | ALG510 | Mannuronate oligosaccharides Average DP10 (sodium salt) | 100mg | 19915.5 |
elicityl-oligotech | GLY011-90% | Lacto-N-Triaose (LNT2) (>90% NMR) | 25mg | 18700 |
elicityl-oligotech | GLY060-95% | 3 Fucosyllactose (3-FL) (>95% NMR) | 100mg | 18700 |
elicityl-oligotech | GLY090-AP | 3'-Sialyllactose-β-Aminopropyl / GM3 Ganglioside oligosaccharide-β-aminopropyl (Sodium salt) | 5mg | 20102.5 |
elicityl-oligotech | GLY090-NPR | 3'-Sialyllactose-β-NAc-propargyl / GM3 Ganglioside oligosaccharide-β-NAc-propargyl (Sodium salt) | 5mg | 20102.5 |
elicityl-oligotech | GLY096-95% | GM1a Ganglioside oligosaccharide (>95%) (Sodium salt) | 25mg | 20196 |
elicityl-oligotech | ALG300 | Guluronate oligosaccharides average DP20 (sodium salt) | 1000mg | 20383 |
elicityl-oligotech | GLU435-90% | Chitin oligosaccharides DP5 / chitinpentaose (>90% RMN) | 75mg | 19074 |
elicityl-oligotech | GLY006-NPR | Core type 2 triaose-β-N-acetyl-propargyl | 5mg | 19167.5 |
elicityl-oligotech | GLY010-NPR | Lacto-N-tetraose-β-N-acetyl-propargyl | 5mg | 19167.5 |
elicityl-oligotech | GLY010-OAPb | Lacto-N-tetraose-β-O-aminopropyl | 5mg | 19167.5 |
elicityl-oligotech | GLY021-NPR | LNnT-β-N-acetyl-propargyl | 5mg | 19167.5 |
elicityl-oligotech | GLY022-NPR | Para-LNnH-NAc-propargyl | 5mg | 19167.5 |
elicityl-oligotech | GLY031-3-NAc-sp1-NH2 | 2’Fucosyllactose-NAc-CH2-(1.4-Tz)-(CH2)2-EG3-NH2 | 1mg | 19167.5 |
elicityl-oligotech | GLY032-2-NAc-sp1-NH2 | Blood group H antigen tetraose type 2-NAc-CH2-(1.4-Tz)-(CH2)2-EG3-NH2 | 1mg | 19167.5 |
elicityl-oligotech | GLY032-2-NPR | Blood group H antigen tetraose type 2-NAc-Propargyl | 5mg | 19167.5 |
elicityl-oligotech | GLY033-1-NPR | Blood group H antigen pentaose type 1-NAcetyl-Propargyl | 5mg | 19167.5 |
elicityl-oligotech | GLY034-NPR | Blood group A antigen triaose-NAc-propargyl | 5mg | 19167.5 |
elicityl-oligotech | GLY035-3-NPR | Blood group A antigen tetraose type 5-N-acetyl-propargyl | 5mg | 19167.5 |
elicityl-oligotech | GLY036-1-OPR | Blood group A antigen pentaose type 1-β-O-Propargyl | 1mg | 19167.5 |
elicityl-oligotech | GLY038-3-NPR | Blood group B antigen tetraose type 5-NAc-propargyl | 5mg | 19167.5 |
elicityl-oligotech | GLY040-1-NPR | Blood group B antigen hexaose type 1-β-NAc-propargyl | 1mg | 19167.5 |
elicityl-oligotech | GLY050-NAc-sp1-NH2 | Lewis X tetraose-NAc-CH2-(1.4-Tz)-(CH2)2-EG3-NH2 | 1mg | 19167.5 |
elicityl-oligotech | GLY050-NPR | Lewis x tetraose -NAc-propargyl | 5mg | 19167.5 |
elicityl-oligotech | GLY050-OAPa | Lewis x tetraose-α-O-aminopropyl | 1mg | 19167.5 |
elicityl-oligotech | GLY050-OAPb | Lewis x tetraose-β-O-aminopropyl | 1mg | 19167.5 |
elicityl-oligotech | GLY053-NPR | Sialyl Lewis x pentaose -N-acetyl-propargyl - Sodium salt | 5mg | 19167.5 |
elicityl-oligotech | GLY054-NPR | Lewis a tetraose-N-acetyl-propargyl | 5mg | 19167.5 |
elicityl-oligotech | GLY060-NPR | 3 Fucosyllactose-NAc-propargyl | 5mg | 19167.5 |
elicityl-oligotech | GLY070-NPR | Isoglobotriaose (IsoGb3)-NAc-propargyl | 5mg | 19167.5 |
elicityl-oligotech | GLY070-OAPb | Isoglobotriaose (IsoGb3)-β-O-aminopropyl | 1mg | 19167.5 |
elicityl-oligotech | GLY103-NPR | Fucosyl GM1 Ganglioside oligosaccharide-NAc-propargyl (Sodium salt) | 1mg | 19167.5 |
elicityl-oligotech | GLY104-NPR | aGM2 Ganglioside oligosaccharide-NAc-propargyl (Sodium salt) | 1mg | 19167.5 |
elicityl-oligotech | GLY120-NAc-sp1-NH2 | Globotriaose (Gb3)-NAc-CH2-(1.4-Tz)-(CH2)2-EG3-NH2 | 1mg | 19167.5 |
elicityl-oligotech | GLY123-NPR | Globo-H-β-NAc-propargyl / SSEA3b-β-NAc-propargyl | 1mg | 19167.5 |
elicityl-oligotech | GLY124-NPR | Globo-A heptaose-NAc-propargyl | 1mg | 19167.5 |
elicityl-oligotech | GLY125-NPR | Globo-B heptaose-NAc-propargyl | 1mg | 19167.5 |
elicityl-oligotech | GLY131-NPR | SSEA-4 hexaose-NAc-propargyl | 1mg | 19167.5 |
elicityl-oligotech | GLU322-90% | Malto-Oligosaccharides Kit 100 mg DP 2 to 7 and 10 mg DP8 DP9 and DP10 (>90% HPLC) | 100mg | 19261 |
elicityl-oligotech | GLY051-BSA | Lewis x hexaose (LNnDFH) linked to BSA | 1mg | 19261 |
elicityl-oligotech | GLY066-BSA | Lactodifucotetraose (DF-L) linked to BSA | 1mg | 19261 |
elicityl-oligotech | GLY071-BSA | Galili antigen pentaose linked to BSA | 1mg | 19261 |
elicityl-oligotech | GLY071-NAc-sp1-NH2 | Galili antigen pentaose-NAc-CH2-(1.4-Tz)-(CH2)2-EG3-NH2 | 1mg | 19261 |
elicityl-oligotech | GLY077-BSA | Galili antigen heptaose linked to BSA | 1mg | 19261 |
elicityl-oligotech | GLY131-90% | SSEA-4 hexaose / Stage-Specific Embryonic Antigen-4 hexaose (>90% NMR) | 10mg | 19261 |
elicityl-oligotech | GLY066-90% | Lactodifucotetraose / Difucosyllactose / DF-L (>90% NMR) | 10mg | 19354.5 |
elicityl-oligotech | GLY155 | GlcNAcβ1-3Gal | 100mg | 19448 |
elicityl-oligotech | MAN600 | Glucomannan polysaccharide from Konjac | 10000mg | 19541.5 |
elicityl-oligotech | GLU320-95% | Maltodecaose DP10 (>95% HPLC) | 500mg | 19635 |
elicityl-oligotech | GAT100 | Galacturonate polysaccharides LM from apple (sodium salt) | 10000mg | 19728.5 |
elicityl-oligotech | GLU306-98% | Cellooctaose (>98% HPAEC-PAD) | 10mg | 19728.5 |
elicityl-oligotech | GLU600 | Lichenan polysaccharide | 10000mg | 20009 |
elicityl-oligotech | GAL110 | Sulfated Arabinogalactan oligosaccharides (cut-off < 10kDA) | 100mg | 20102.5 |
elicityl-oligotech | GAT112 | Galacturonan oligosaccharides Mixture DP7/DP8 | 100mg | 20102.5 |
elicityl-oligotech | GAT11x | Galacturonan oligosaccharides Mixture DP5/DP7 | 100mg | 20102.5 |
elicityl-oligotech | GLU432-90% | Chitin oligosaccharides DP2 /chitinbiose (>90% RMN) | 100mg | 20102.5 |
elicityl-oligotech | GLU433-90% | Chitin oligosaccharides DP3 / chitintriose (>90% RMN) | 100mg | 20102.5 |
elicityl-oligotech | GLY034-OAP | Blood group A antigen triaose-β-O-aminopropyl | 5mg | 20102.5 |
elicityl-oligotech | GLY058-AP | Blood group B antigen triaose-β-O-aminopropyl | 5mg | 20102.5 |
elicityl-oligotech | MAN219 | Galactomannan oligosaccharides DP9 from Carob | 100mg | 20102.5 |
elicityl-oligotech | MAN810 | Mannan oligosaccharides (cut-off | 100mg | 20102.5 |
elicityl-oligotech | GLY153-90% | α1-3 galactobiose / Galα1-3Gal (>90% NMR) | 100mg | 20289.5 |
elicityl-oligotech | ALG320 | Guluronate oligosaccharides average DP5 (sodium salt) | 100mg | 21879 |
elicityl-oligotech | ALG520 | Mannuronate oligosaccharides Average DP5 (sodium salt) | 100mg | 21879 |
elicityl-oligotech | GLY007-90% | Di-N-Acetyl-D-Lactosamine (>90% NMR) | 25mg | 20570 |
elicityl-oligotech | GLY078-BSA | Galili antigen nonaose linked to BSA | 1mg | 20570 |
elicityl-oligotech | GLY011-95% | Lacto-N-Triaose (LNT2) (>95% HPLC) | 25mg | 20663.5 |
elicityl-oligotech | GLY126-90% | Core type 4 (Gb5 triaose core structure) | 25mg | 20663.5 |
elicityl-oligotech | GLY034-90% | Blood group A antigen triaose | 25mg | 20850.5 |
elicityl-oligotech | GLY090-90% | 3'-Sialyllactose / GM3 Ganglioside oligosaccharide (>90% NMR) (Sodium salt) | 2000mg | 22440 |
elicityl-oligotech | GLU511 | Curdlan polysaccharide β-(1-3) linked linear glucan prepared by bacterial fermentation | 10000mg | 21037.5 |
elicityl-oligotech | GLU302-98% | Cellotetraose (>98% HPAEC-PAD) | 100mg | 21131 |
elicityl-oligotech | GLY031-3-13C labelled | 2'FL labelled 13C | 25mg | 21131 |
elicityl-oligotech | GLY090-GEL | 3'-Sialyllactose grafted on gel matrix (3'SL-Gel) 1 ml | 1ml | 22627 |
elicityl-oligotech | GLY063 | 3’Sialyl-3Fucosyllactose / F-SL (Sodium salt) | 25mg | 21318 |
elicityl-oligotech | GLY084-2-90% | Sialylated triaose type 2/ 3'-α-sialyl-Acetyl-Lactosamine/ sialyl Lex precursor (>90% NMR) (Sodium salt) | 25mg | 21598.5 |
elicityl-oligotech | MAN300 | α-Digalactosyl mannopentaose | 100mg | 21598.5 |
elicityl-oligotech | XYL100 | Xylan polysaccharide from Palmaria palmata | 10000mg | 21598.5 |
elicityl-oligotech | GLY094-90% | GD2 Ganglioside oligosaccharide (>90%) (Sodium salt) | 10mg | 23188 |
elicityl-oligotech | GLY032-1-80% | Blood group H antigen tetraose type 1 (>80% NMR) | 25mg | 21692 |
elicityl-oligotech | GLY153-90% | α1-3 galactobiose / Galα1-3Gal (>90% NMR) | 150mg | 21692 |
elicityl-oligotech | GAT111 | Galacturonan oligosaccharides Mixture DP3/DP4 | 100mg | 21879 |
elicityl-oligotech | GLU303-90% | Cellopentaose (>90% HPAEC-PAD) | 100mg | 21879 |
elicityl-oligotech | GLU421 | Chitosan oligosaccharides mixture | 1000mg | 21879 |
elicityl-oligotech | GLU434-90% | Chitin oligosaccharides DP4 / chitintetraose (>90% RMN) | 100mg | 21879 |
elicityl-oligotech | GLU435-90% | Chitin oligosaccharides DP5 / chitinpentaose (>90% RMN) | 100mg | 21879 |
elicityl-oligotech | MAN213 | Galactomannan oligosaccharides DP3 from Carob | 100mg | 21879 |
elicityl-oligotech | MAN215 | Galactomannan oligosaccharides DP5 from Carob | 100mg | 21879 |
elicityl-oligotech | XYL101 | Glucurono-Arabinoxylan PLS from wheat bran | 1000mg | 21879 |
elicityl-oligotech | GLY120-GEL | Globotriaose (Gb3) / Pk antigen grafted on gel | 1mg | 21972.5 |
elicityl-oligotech | GLY012-90% | Para-Lacto-N-hexaose (Para-LNH) | 25mg | 22159.5 |
elicityl-oligotech | FRU113-95% | Fructo-oligosaccharide DP7 / GF6 / 1-F-(1-β-fructofuranosyl)-3-nystose (>95% HPAEC-PAD) | 25mg | 22253 |
elicityl-oligotech | FRU113-90% | Fructo-oligosaccharide DP7 / GF6 / 1-F-(1-β-fructofuranosyl)-3-nystose (>90% HPAEC-PAD) | 25mg | 22253 |
elicityl-oligotech | GLY122-85% | Globopentaose (Gb5) / Stage Specific Embryonic Antigen 3a (SSEA-3a) (>85% NMR) | 50mg | 22346.5 |
elicityl-oligotech | GLY129-90% | Blood group B antigen pentasaccharide type 4 (>90% NMR) | 25mg | 22346.5 |
elicityl-oligotech | MAN802 | Mannan polysaccharide from Yeast | 1000mg | 22440 |
elicityl-oligotech | HGL100 | Sulfated heteropolysaccharides native grade | 100mg | 22627 |
elicityl-oligotech | GLY111-80% | GM2 Ganglioside oligosaccharide analogue (>80% NMR) (Sodium salt) | 25mg | 22720.5 |
elicityl-oligotech | GLY092-80% | GT3 Ganglioside oligosaccharide (>80%) (Sodium salt) | 25mg | 24310 |
elicityl-oligotech | GLY031-3-90% | Blood group H antigen triaose type 5 / 2’Fucosyllactose / 2'FL (>90% NMR) | 500mg | 22814 |
elicityl-oligotech | GLY121-90% | Globotetraose (Gb4) / P antigen (>90% NMR) | 50mg | 22814 |
elicityl-oligotech | GLY066-95% | Lactodifucotetraose / Difucosyllactose / DF-L (>95% NMR) | 10mg | 23001 |
elicityl-oligotech | ALG530 | Mannuronate oligosaccharides DP3 (sodium salt) | 100mg | 24684 |
elicityl-oligotech | FRU112-95% | Fructo-oligosaccharide DP6 / GF5 / 1-F-(1-β-fructofuranosyl)-2-nystose (>95% HPAEC-PAD) | 25mg | 23188 |
elicityl-oligotech | HGL101 | Sulfated heteropolysaccharides fine grade | 100mg | 23655.5 |
elicityl-oligotech | FRU114-90% | Fructo-oligosaccharide DP8 / GF7 (>90% HPAEC-PAD) | 25mg | 23842.5 |
elicityl-oligotech | FRU118-90% | Fructo-oligosaccharide DP12 / GF11 (>90% HPAEC-PAD) | 50mg | 23842.5 |
elicityl-oligotech | FRU114-95% | Fructo-oligosaccharide DP8 / GF7 (>95% HPAEC-PAD) | 25mg | 23842.5 |
elicityl-oligotech | GLY007-2-85% | Tri-N-Acetyl-D-Lactosamine (>85% NMR) | 25mg | 23936 |
elicityl-oligotech | ULV005 | Ulvan oligosaccharides (Cut-off: between 3 & 5kDa) from Enteromorpha sp. | 100mg | 23936 |
elicityl-oligotech | GLY031-1-BSA | Blood group H antigen triaose type 1 linked to BSA | 5mg | 24684 |
elicityl-oligotech | GLY033-1-BSA | Blood group H antigen pentaose type 1 linked to BSA | 5mg | 24684 |
elicityl-oligotech | GLY040-1-90% | Blood group B antigen hexaose type 1 (>90% NMR) | 25mg | 24684 |
elicityl-oligotech | GLY040-2-90% | Blood group B antigen hexaose type 2 (>90% NMR) | 25mg | 24684 |
elicityl-oligotech | GLY055-90% | Lewis a (Le a) hexaose / Lacto-N-difucohexaose II (LNDFH II) (>90% NMR) | 50mg | 24684 |
elicityl-oligotech | GLY060-BSA | 3 Fucosyllactose linked to BSA | 5mg | 24684 |
elicityl-oligotech | GLY079-BSA | Galili antigen undecaose linked to BSA | 1mg | 24684 |
elicityl-oligotech | GLY053-80% | Sialyl Lewis x (sLe x) pentaose - Sodium salt (>80% NMR) | 5mg | 24871 |
elicityl-oligotech | GLU303-95% | Cellopentaose (>95% HPAEC-PAD) | 100mg | 25151.5 |
elicityl-oligotech | ALG600 | Manuronic Block OLS. DP30-DP50 M/G ratio>4 | 1000mg | 25338.5 |
elicityl-oligotech | GLY050-90% | Lewis x (LeX) tetraose (>90% NMR) | 50mg | 25432 |
elicityl-oligotech | ALG330 | Guluronate oligosaccharides average DP3 (sodium salt) | 100mg | 27302 |
elicityl-oligotech | GLY031-2-95% | Blood group H antigen triaose type 2 (>95% NMR) | 100mg | 25806 |
elicityl-oligotech | GLY031-2-90% | Blood group H antigen triaose type 2 (>90% NMR) | 100mg | 25806 |
elicityl-oligotech | GLY022-90% | Para-Lacto-N-neohexaose (Para-LNnH) (>90% NMR) | 25mg | 25993 |
elicityl-oligotech | GLY024-90% | Galacto-N-Neopentaose Di LAcNac Gal (>90% NMR) | 25mg | 25993 |
elicityl-oligotech | GLY032-1-90% | Blood group H antigen tetraose type 1 (>90% NMR) | 25mg | 25993 |
elicityl-oligotech | GLY037-1-90% | Blood group A antigen hexaose type 1 (>90% NMR) | 25mg | 25993 |
elicityl-oligotech | GLY037-2-90% | Blood group A antigen hexaose type 2 (>90% NMR) | 25mg | 25993 |
elicityl-oligotech | GLY123-90% | Globo-H hexaose / Stage Specific Embryonic Antigen 3b (SSEA-3b) (>90% NMR) | 25mg | 25993 |
elicityl-oligotech | GLY128-90% | Blood group A antigen pentaose type 4 (>90% NMR) | 25mg | 25993 |
elicityl-oligotech | GLY250-80% | Galα1-4Galα1-4Galβ1-4Glc / Galα1-4Gb3 (> 80% NMR) | 25mg | 25993 |
elicityl-oligotech | GLY010-90% | Lacto-N-tetraose (LNT) (>90% NMR) | 100mg | 26086.5 |
elicityl-oligotech | GLY120-90% | Globotriaose (Gb3) / Pk antigen (>90% HPLC) | 100mg | 26086.5 |
elicityl-oligotech | GLY120-NPR | Globotriaose (Gb3)-NAc-propargyl | 5mg | 26086.5 |
elicityl-oligotech | GLY031-3-90% | Blood group H antigen triaose type 5 / 2’Fucosyllactose / 2'FL (>90% NMR) | 1000mg | 26367 |
elicityl-oligotech | LEC101 | LecB (PA-IIL) from Pseudomonas aeruginosa - (Bacterial protein produced in E. coli) | 5mg | 26741 |
elicityl-oligotech | LEC102 | LecA (PA-IL) from Pseudomonas aeruginosa - (Bacterial protein produced in E. coli) | 5mg | 26741 |
elicityl-oligotech | FRU115-90% | Fructo-oligosaccharide DP9 / GF8 (>90% HPAEC-PAD) | 25mg | 27115 |
elicityl-oligotech | GLY035-1-90% | Blood group A antigen tetraose type 1 (>90% NMR) | 25mg | 27115 |
elicityl-oligotech | GLY038-1-90% | Blood group B antigen tetraose type 1 (>90% NMR) | 25mg | 27115 |
elicityl-oligotech | GLY064-60% | α-3Galactosyl-3Fucosyllactose (>60% NMR) | 25mg | 27115 |
elicityl-oligotech | FRU115-95% | Fructo-oligosaccharide DP9 / GF8 (>95% HPAEC-PAD) | 25mg | 27115 |
elicityl-oligotech | MAN800 | Mannan polysaccharide (Ivory Nut or Tagua) - 1.4-beta-D-Mannan | 10000mg | 27208.5 |
elicityl-oligotech | GLY092-90% | GT3 Ganglioside oligosaccharide (>90%) (Sodium salt) | 25mg | 29172 |
elicityl-oligotech | GLY091-90% | GD3 Ganglioside oligosaccharide / Disialyl lactose/ DS-L (>90%) (Sodium salt) | 25mg | 29172 |
elicityl-oligotech | GLY097-90% | GM1b Ganglioside oligosaccharide (>90%) (Sodium salt) | 25mg | 29172 |
elicityl-oligotech | FUC200 | Galactofucan polysaccharide from Undaria pinnatifida | 1000mg | 27302 |
elicityl-oligotech | GAL101 | Sulfated Arabinogalactan polysaccharide (from Codium f.) Fine grade | 1000mg | 27302 |
elicityl-oligotech | GAL111 | Sulfated Arabinogalactan oligosaccharides (Cut-off: between 3kDA & 10kDA) | 100mg | 27302 |
elicityl-oligotech | GLU304-80% | Cellohexaose (>80% HPAEC-PAD) | 100mg | 27302 |
elicityl-oligotech | GLU436-90% | Chitin oligosaccharides DP6 / chitinhexaose (>90% RMN) | 100mg | 27302 |
elicityl-oligotech | ULV006 | Ulvan oligosaccharides (Cut-off: between 1 & 3kDa ) from Enteromorpha sp. | 100mg | 27302 |
elicityl-oligotech | ULV100 | Ulvan polysaccharides from Ulva sp. Native grade | 10000mg | 27302 |
elicityl-oligotech | ULV101 | Ulvan polysaccharides from Enteromorpha sp. Native grade | 10000mg | 27302 |
elicityl-oligotech | XYL111 | Xylan oligosaccharides XOs (Cut-off: between 650Da & 3kDa) from Palmaria p. | 100mg | 27302 |
elicityl-oligotech | GLY010-90% | Lacto-N-tetraose (LNT) (>90% NMR) | 150mg | 27863 |
elicityl-oligotech | FRU116-95% | Fructo-oligosaccharide DP10 / GF9 (>95% HPAEC-PAD) | 25mg | 27863 |
elicityl-oligotech | GLU322-98% | Malto-Oligosaccharides Kit 100 mg DP 2 to 7 and 10 mg DP8 DP9 and DP10 (>98% HPLC) | 100mg | 27956.5 |
elicityl-oligotech | GLY010-95% | Lacto-N-tetraose (LNT) (>95% HPLC) | 100mg | 28143.5 |
elicityl-oligotech | GLY093-90% | GM2 Ganglioside oligosaccharide (>90%) (Sodium salt) | 25mg | 30387.5 |
elicityl-oligotech | GLY021-90% | Lacto-N-neotetraose (LNnT / neo-LNT) | 100mg | 28517.5 |
elicityl-oligotech | GLY031-3-95% | Blood group H antigen triaose type 5 / 2’Fucosyllactose / 2'FL (>95% NMR) | 1000mg | 28517.5 |
elicityl-oligotech | GLY031-1-70% | Blood group H antigen triaose type 1 (>70% NMR) | 25mg | 28611 |
elicityl-oligotech | GLY031-1-80% | Blood group H antigen triaose type 1 (>80% NMR) | 25mg | 28611 |
elicityl-oligotech | GLY031-1-90% | Blood group H antigen triaose type 1 (>90% NMR) | 25mg | 28611 |
elicityl-oligotech | GLY031-1-95% | Blood group H antigen triaose type 1 (>95% NMR) | 25mg | 28611 |
elicityl-oligotech | GLY122-90% | Globopentaose (Gb5) / Stage Specific Embryonic Antigen 3a (SSEA-3a) (>90% NMR) | 50mg | 28611 |
elicityl-oligotech | REF089 | 2,6'-Sialyllactose (6'SL) (Sodium salt) Analytical Reference | 50mg | 28798 |
elicityl-oligotech | GAT114 | Galacturonan oligosaccharides Mixture DP10/DP15 | 1000mg | 28891.5 |
elicityl-oligotech | GLU303-98% | Cellopentaose (>98% HPAEC-PAD) | 100mg | 28891.5 |
elicityl-oligotech | GLY163-80% | 2'2 Difucosyllactose (>80% NMR) | 25mg | 28985 |
elicityl-oligotech | GLY005-90% | Core type 1 triaose | 25mg | 29172 |
elicityl-oligotech | GLY006-90% | Core type 2 triaose | 25mg | 29172 |
elicityl-oligotech | GLY007-3-90% | Tetra-N-Acetyl-D-Lactosamine | 25mg | 29172 |
elicityl-oligotech | GLY033-2-90% | Blood group H antigen pentaose type 2 / Lacto-N-neofucopentaose I (LnNFP I) (>90% NMR) | 25mg | 29172 |
elicityl-oligotech | GLY035-2-90% | Blood group A antigen tetraose type 2 | 25mg | 29172 |
elicityl-oligotech | GLY035-4-90% | Blood group A Lewisb antigen pentaose type 1 | 25mg | 29172 |
elicityl-oligotech | GLY035-5-85% | Blood group A LewisY antigen pentaose type 2 | 25mg | 29172 |
elicityl-oligotech | GLY038-2-90% | Blood group B antigen tetraose type 2 (>90% NMR) | 25mg | 29172 |
elicityl-oligotech | GLY038-4-90% | Blood group B Lewisb antigen pentaose type 1 (>90% NMR) | 25mg | 29172 |
elicityl-oligotech | GLY038-5-90% | Blood group B LewisY antigen pentaose type 2 | 25mg | 29172 |
elicityl-oligotech | GLY052-90% | Lewis y (LeY) pentaose (>90% NMR) | 50mg | 29172 |
elicityl-oligotech | GLY067-70% | 3-Fucosylated Blood group A tetraose | 25mg | 29172 |
elicityl-oligotech | GLY068 | 3-Fucosylated Blood group B tetraose | 25mg | 29172 |
elicityl-oligotech | GLY072-90% | Isoglobotetraose / iGb4 / Cytolipin R (>90% NMR) | 25mg | 29172 |
elicityl-oligotech | GLY073-90% | Isoglobopentaose / iGb5 | 25mg | 29172 |
elicityl-oligotech | GLY074-1-85% | Xeno antigen type 1 (>85% NMR) | 25mg | 29172 |
elicityl-oligotech | GLY075-90% | Xeno lewisX / α-Gal-LewisX | 25mg | 29172 |
elicityl-oligotech | GLY103-90% | Fucosyl GM1 Ganglioside oligosaccharide (>90% NMR) (Sodium salt) | 25mg | 29172 |
elicityl-oligotech | GLY111-90% | GM2 Ganglioside oligosaccharide analogue (>90% NMR) (Sodium salt) | 25mg | 29172 |
elicityl-oligotech | GLY124-90% | Globo-A heptaose | 25mg | 29172 |
elicityl-oligotech | GLY125-90% | Globo-B heptaose (>90% NMR) | 25mg | 29172 |
elicityl-oligotech | GLY127-90% | Blood group H antigen tetraose type 4 / Globo H tetraose -NAc-CH2-(1.4-Tz)-(CH2)2-EG3-NH2 | 25mg | 29172 |
elicityl-oligotech | GLY130-85% | SSEA-4 tetraose / Stage-Specific Embryonic Antigen-4 tetraose | 25mg | 29172 |
elicityl-oligotech | GLY132-90% | Forssman antigen pentaose | 25mg | 29172 |
elicityl-oligotech | GLY133-90% | Forssman antigen triaose | 25mg | 29172 |
elicityl-oligotech | GLY164 | Fucosylated A antigen type 5 | 25mg | 29172 |
elicityl-oligotech | GLY165-90% | Fucosylated B antigen type 5 (>90% NMR) | 25mg | 29172 |
elicityl-oligotech | GLY181-90% | Glucuronyl-LNT / Glucuronyl-Lacto-N-tetraose (>90% NMR) (Sodium salt) | 25mg | 29172 |
elicityl-oligotech | GLY190 | Globotetraose analogue / Gb4 analogue | 25mg | 29172 |
elicityl-oligotech | GLY191-1-90% | Globopentaose analogue type 1 / Gb5 analogue type 1 | 25mg | 29172 |
elicityl-oligotech | GLY191-2-90% | Globopentaose analogue type 2 / Gb5 analogue type 2 | 25mg | 29172 |
elicityl-oligotech | GLY194-1 | Globo-H analogue type 1 | 25mg | 29172 |
elicityl-oligotech | GLY194-2-90% | Globo-H analogue type 2 | 25mg | 29172 |
elicityl-oligotech | GLY195-1 | SSEA-4 hexaose analogue type 1 | 25mg | 29172 |
elicityl-oligotech | GLY195-2 | SSEA-4 hexaose analogue type 2 | 25mg | 29172 |
elicityl-oligotech | GLY196-1-75% | Sialylated-SSEA-4 hexaose analogue type 1 | 25mg | 29172 |
elicityl-oligotech | GLY197 | Isoglobotetraose analogue / iGb4 analogue | 25mg | 29172 |
elicityl-oligotech | GLY198-1 | Isoglobopentaose analogue type 1 / iGb5 analogue type 1 | 25mg | 29172 |
elicityl-oligotech | GLY201-1 | Isoglobo-H analogue type 1 | 25mg | 29172 |
elicityl-oligotech | GLY201-2 | Isoglobo-H analogue type 2 | 25mg | 29172 |
elicityl-oligotech | GLY202-1 | Sialylated isoglobopentaose analogue type 1 / Sialylated iGb5 analogue type 1 | 25mg | 29172 |
elicityl-oligotech | GLY202-2 | Sialylated isoglobopentaose analogue type 2 / Sialylated iGb5 analogue type 2 | 25mg | 29172 |
elicityl-oligotech | GLU1000 | Xyloglucan oligosaccharides | 10000mg | 29639.5 |
elicityl-oligotech | GLY010-90% | Lacto-N-tetraose (LNT) (>90% NMR) | 250mg | 29733 |
elicityl-oligotech | GLY035-3-EG2-NH2 | Blood group A antigen tetraose type 5-EG2-NH2 | 1mg | 29826.5 |
elicityl-oligotech | GLY035-3-NAc-sp1-NH2 | Blood group A antigen tetraose type 5-NAc-CH2-(1.4-Tz)-(CH2)2-EG3-NH2 | 1mg | 29826.5 |
elicityl-oligotech | GLY035-3-NAc-sp2-NH2 | Blood group A antigen tetraose type 5-NAc-CH2-(1.4-Tz)-(CH2)2-EG7-NH2 | 1mg | 29826.5 |
elicityl-oligotech | GLY035-3-O-S-NH2-90% | Blood group A antigen tetraose type 5-O-S-NH2 (>90% NMR) | 1mg | 29826.5 |
elicityl-oligotech | GLY037-1-NAc-sp1-NH2 | Blood group A antigen hexaose type 1-NAc-CH2-(1.4-Tz)-(CH2)2-EG3-NH2 | 1mg | 29826.5 |
elicityl-oligotech | GLY037-1-NAc-sp2-NH2 | Blood group A antigen hexaose type 1-NAc-CH2-(1.4-Tz)-(CH2)2-EG7-NH2 | 1mg | 29826.5 |
elicityl-oligotech | GLY037-1-NAc-sp4-NH2 | Blood group A antigen hexaose type 1-NAc-CH2-(1.4-Tz)-(CH2)6-NH2 | 1mg | 29826.5 |
elicityl-oligotech | GLY038-3-EG2-NH2 | Blood group B antigen tetraose type 5-EG2-NH2 | 1mg | 29826.5 |
elicityl-oligotech | GLY038-3-NAc-sp1-NH2 | Blood group B antigen tetraose type 5-NAc-CH2-(1.4-Tz)-(CH2)2-EG3-NH2 | 1mg | 29826.5 |
elicityl-oligotech | GLY038-3-O-S-NH2-90% | Blood group B antigen tetraose type 5-O-S-NH2 (>90% NMR) | 1mg | 29826.5 |
elicityl-oligotech | GLY053-90% | Sialyl Lewis x (sLe x) pentaose - Sodium salt (>90% NMR) | 5mg | 29826.5 |
elicityl-oligotech | GLY080 | Sialylated tetraose type 1 (Sodium salt) | 25mg | 29826.5 |
elicityl-oligotech | GLY120-NAc-sp3-Bt | Globotriaose (Gb3)-NAc-CH2-(1.4-Tz)-(CH2)2-EG3-NH-Biotin | 1mg | 29826.5 |
elicityl-oligotech | GLY121-NAc-sp3-Bt | Globotetraose (Gb4)-Biotin | 1mg | 29826.5 |
elicityl-oligotech | GLY122-NAc-sp3-Bt | Globopentaose (Gb5)-Biotin | 1mg | 29826.5 |
elicityl-oligotech | GLY123-NAc-sp1-NH2-90% | Globo-H hexaose (SSEA-3b)-NAc-CH2-(1.4-Tz)-(CH2)2-EG3-NH2 (>90% NMR) | 1mg | 29826.5 |
elicityl-oligotech | GLY131-NAc-sp1-NH2 | SSEA-4 hexaose-NAc-CH2-(1.4-Tz)-(CH2)2-EG3-NH2 | 1mg | 29826.5 |
elicityl-oligotech | GLY033-2-NPR | Blood group H antigen pentaose type 2-NAc-propargyl | 5mg | 29920 |
elicityl-oligotech | GLU310 | Maltodextrin High DP10-40 oligosaccharide mixture | 2000mg | 30107 |
elicityl-oligotech | GLY010-95% | Lacto-N-tetraose (LNT) (>95% HPLC) | 150mg | 30107 |
elicityl-oligotech | GLY093-NAc-sp1-NH2 | GM2 Ganglioside oligosaccharide-NAc-CH2-(1.4-Tz)-(CH2)2-EG3-NH2 (Sodium salt) | 1mg | 32257.5 |
elicityl-oligotech | GLY091-NAc-sp1-NH2 | GD3 Ganglioside oligosaccharide -NAc-CH2-(1.4-Tz)-(CH2)2-EG3-NH2 | 1mg | 32257.5 |
elicityl-oligotech | GLY098-NAc-sp1-NH2 | GD1a Ganglioside oligosaccharide-NAc-CH2-(1.4-Tz)-(CH2)2-EG3-NH2 | 1mg | 32257.5 |
elicityl-oligotech | GLY035-3-90% | Blood group A antigen tetraose type 5 (>90% NMR) | 100mg | 30387.5 |
elicityl-oligotech | GLY083-70% | LS-Tetrasaccharide d (LSTd) / Sialyl-lacto-N-neotetraose d (>70% NMR) (Sodium salt) | 100mg | 30481 |
elicityl-oligotech | GLY180-50% | Glucuronyl-lactose / HNK 1 epitope precursor (Sodium salt) | 100mg | 31042 |
elicityl-oligotech | GLU322-99% | Malto-Oligosaccharides Kit 100 mg DP 2 to 7 (>99% HPLC) and 10 mg DP8 DP9 and DP10 (>98% HPLC) | 100mg | 31229 |
elicityl-oligotech | GLY009-90% | Lacto-N-Biose (>90% HPLC) | 100mg | 31229 |
elicityl-oligotech | GLY032-2-90% | Blood group H antigen tetraose type 2 (>90% NMR) | 25mg | 31229 |
elicityl-oligotech | GLY033-1-90% | Blood group H antigen pentaose type 1 / Lacto-N-fucopentaose I (LNFP I) (>90% NMR) | 100mg | 31229 |
elicityl-oligotech | GLY120-98% | Globotriaose (Gb3) / Pk antigen (>98% HPLC) | 100mg | 31509.5 |
elicityl-oligotech | GLY010-95% | Lacto-N-tetraose (LNT) (>95% HPLC) | 250mg | 32070.5 |
elicityl-oligotech | GLY011-90% | Lacto-N-Triaose (LNT2) (>90% NMR) | 50mg | 32070.5 |
elicityl-oligotech | GLY134-90% | Isoforssman antigen pentaose | 25mg | 32257.5 |
elicityl-oligotech | GLY090-90% | 3'-Sialyllactose / GM3 Ganglioside oligosaccharide (>90% NMR) (Sodium salt) | 5000mg | 34782 |
elicityl-oligotech | GLY102-90% | aGM1 (asialo GM1) Ganglioside oligosaccharide / GA1 (>90% NMR) (Sodium salt) | 100mg | 32538 |
elicityl-oligotech | GLY096-80% | GM1a Ganglioside oligosaccharide (>80%) (Sodium salt) | 100mg | 34875.5 |
elicityl-oligotech | GLU304-90% | Cellohexaose (>90% HPAEC-PAD) | 100mg | 32818.5 |
elicityl-oligotech | GLY021-95% | Lacto-N-neotetraose (LNnT / neo-LNT) (>95% HPLC) | 100mg | 32818.5 |
elicityl-oligotech | REF090 | 3'-Sialyllactose (3'SL) (Sodium salt) Analytical Reference | 50mg | 32912 |
elicityl-oligotech | LEC202 | RSL from Ralstonia solanacearum - (Bacterial protein produced in E. coli) | 5mg | 33099 |
elicityl-oligotech | LEC301 | BC2LA from Burkholderia cenocepacia - (Bacterial protein produced in E. coli) | 5mg | 33099 |
elicityl-oligotech | GLU435-90% | Chitin oligosaccharides DP5 / chitinpentaose (>90% RMN) | 150mg | 33286 |
elicityl-oligotech | GLY035-3-95% | Blood group A antigen tetraose type 5 (>95% NMR) | 100mg | 33566.5 |
elicityl-oligotech | GLY062-80% | Lacto-N-fucopentaose V / LNFP V (>80% NMR) | 25mg | 33753.5 |
elicityl-oligotech | GLY098-NPR | GD1a Ganglioside oligosaccharide-β-NAc-propargyl (Sodium salt) | 5mg | 36465 |
elicityl-oligotech | GLY033-1-95% | Blood group H antigen pentaose type 1 / Lacto-N-fucopentaose I (LNFP I) (>95% NMR) | 100mg | 34408 |
elicityl-oligotech | GLU301-90% | Cellotriose (>90% HPAEC-PAD) | 500mg | 34595 |
elicityl-oligotech | GLY011-95% | Lacto-N-Triaose (LNT2) (>95% HPLC) | 50mg | 34688.5 |
elicityl-oligotech | GLU900 | Pustulan polysaccharide | 5000mg | 34782 |
elicityl-oligotech | GLY123-NAc-sp1-NH2-98% | Globo-H hexaose (SSEA-3b)-NAc-CH2-(1.4-Tz)-(CH2)2-EG3-NH2 (>98% NMR) | 1mg | 34875.5 |
elicityl-oligotech | GLY131-NPR | SSEA-4 hexaose-NAc-propargyl | 5mg | 34875.5 |
elicityl-oligotech | GLY031-3-98% | Blood group H antigen triaose type 5 / 2’Fucosyllactose / 2'FL (>98% HPLC) | 1000mg | 35062.5 |
elicityl-oligotech | GLY157-90% | 3 Sialylgalactose - GM4 (>90% NMR) | 100mg | 35156 |
elicityl-oligotech | GLY006-NPR | Core type 2 triaose-β-N-acetyl-propargyl | 25mg | 35343 |
elicityl-oligotech | GLY010-NPR | Lacto-N-tetraose-β-N-acetyl-propargyl | 25mg | 35343 |
elicityl-oligotech | GLY010-OAPb | Lacto-N-tetraose-β-O-aminopropyl | 25mg | 35343 |
elicityl-oligotech | GLY021-NPR | LNnT-β-N-acetyl-propargyl | 25mg | 35343 |
elicityl-oligotech | GLY022-NPR | Para-LNnH-NAc-propargyl | 25mg | 35343 |
elicityl-oligotech | GLY032-2-NPR | Blood group H antigen tetraose type 2-NAc-Propargyl | 25mg | 35343 |
elicityl-oligotech | GLY033-1-NPR | Blood group H antigen pentaose type 1-NAcetyl-Propargyl | 25mg | 35343 |
elicityl-oligotech | GLY034-NPR | Blood group A antigen triaose-NAc-propargyl | 25mg | 35343 |
elicityl-oligotech | GLY035-3-NPR | Blood group A antigen tetraose type 5-N-acetyl-propargyl | 25mg | 35343 |
elicityl-oligotech | GLY038-3-NPR | Blood group B antigen tetraose type 5-NAc-propargyl | 25mg | 35343 |
elicityl-oligotech | GLY050-NPR | Lewis x tetraose -NAc-propargyl | 25mg | 35343 |
elicityl-oligotech | GLY053-NPR | Sialyl Lewis x pentaose -N-acetyl-propargyl - Sodium salt | 25mg | 35343 |
elicityl-oligotech | GLY090-NPR | 3'-Sialyllactose-β-NAc-propargyl / GM3 Ganglioside oligosaccharide-β-NAc-propargyl (Sodium salt) | 25mg | 38054.5 |
elicityl-oligotech | GLY123-NAc-sp3-Bt | Globo-H-Biotin | 1mg | 36184.5 |
elicityl-oligotech | GLY124-NAc-sp3-Bt | Globo-A heptaose-Biotin | 1mg | 36184.5 |
elicityl-oligotech | GLY125-NAc-sp3-Bt | Globo-B heptaose-Biotin | 1mg | 36184.5 |
elicityl-oligotech | GLY090-NAc-sp1-NH2 | 3'-Sialyllactose-NAc-CH2-(1.4-Tz)-(CH2)2-EG3-NH2 (Sodium salt) | 5mg | 38802.5 |
elicityl-oligotech | GLU323 | Cellodextrin Oligosaccharide mixture DP | 1000mg | 36371.5 |
elicityl-oligotech | GLY123-NPR | Globo-H-β-NAc-propargyl / SSEA3b-β-NAc-propargyl | 5mg | 36371.5 |
elicityl-oligotech | GAL112 | Sulfated Arabinogalactan oligosaccharides (cut-off < 3kDa) | 100mg | 36465 |
elicityl-oligotech | GLY022-NAc-sp4-NH2 | Para-LNnH-NAc-CH2-(1.4-Tz)-(CH2)6-NH2 | 5mg | 36465 |
elicityl-oligotech | GLY036-1-OPR | Blood group A antigen pentaose type 1-β-O-Propargyl | 5mg | 36465 |
elicityl-oligotech | GLY037-1-NPR | Blood group A antigen hexaose type 1-β-NAc-propargyl | 5mg | 36465 |
elicityl-oligotech | GLY040-1-NAc-sp1-NH2 | Blood group B antigen hexaose type 1-NAc-CH2-(1.4-Tz)-(CH2)2-EG3-NH2 | 5mg | 36465 |
elicityl-oligotech | GLY040-1-NAc-sp2-NH2 | Blood group B antigen hexaose type 1-NAc-CH2-(1.4-Tz)-(CH2)2-EG7-NH2 | 5mg | 36465 |
elicityl-oligotech | GLY040-1-NPR | Blood group B antigen hexaose type 1-β-NAc-propargyl | 5mg | 36465 |
elicityl-oligotech | GLY050-NAc-sp1-NH2 | Lewis X tetraose-NAc-CH2-(1.4-Tz)-(CH2)2-EG3-NH2 | 5mg | 36465 |
elicityl-oligotech | GLY050-OPR | Lewis x tetraose-β-O-propargyl | 5mg | 36465 |
elicityl-oligotech | GLY052-NPR | Lewis y pentaose-NAc-propargyl | 5mg | 36465 |
elicityl-oligotech | GLY052-NAc-sp1-NH2 | Lewis y pentaose-NAc-CH2-(1.4-Tz)-(CH2)2-EG3-NH2 | 5mg | 36465 |
elicityl-oligotech | GLY053-OPR | Sialyl Lewis x pentaose-β-O-propargyl - Sodium salt | 5mg | 36465 |
elicityl-oligotech | GLY054-NAc-sp1-NH2 | Lewis a tetraose-NAc-CH2-(1.4-Tz)-(CH2)2-EG3-NH2 | 5mg | 36465 |
elicityl-oligotech | GLY056-NPR | Lewis b pentaose-N-acetyl-propargyl | 5mg | 36465 |
elicityl-oligotech | GLY071-NPR | Galili antigen pentaose-NAc-propargyl | 5mg | 36465 |
elicityl-oligotech | ULV007 | Ulvan oligosaccharides (Cut-off: between 650Da & 1kDa) from Enteromorpha sp. | 100mg | 36465 |
elicityl-oligotech | ALG601 | Manuronic Block OLS. DP20-DP35 M/G ratio>4 | 1000mg | 37026 |
elicityl-oligotech | ALG610 | Guluronate Block OLS. DP25-DP45 | 1000mg | 37026 |
elicityl-oligotech | GLY163-90% | 2'2 Difucosyllactose (>90% NMR) | 25mg | 37026 |
elicityl-oligotech | REF060 | 3 Fucosyllactose (3-FL) Analytical Reference | 50mg | 37026 |
elicityl-oligotech | REF031-3 | 2’Fucosyllactose (2'FL) Analytical Reference | 50mg | 37026 |
elicityl-oligotech | GLY122-85% | Globopentaose (Gb5) / Stage Specific Embryonic Antigen 3a (SSEA-3a) (>85% NMR) | 100mg | 37119.5 |
elicityl-oligotech | GLU304-95% | Cellohexaose (>95% HPAEC-PAD) | 100mg | 37680.5 |
elicityl-oligotech | GLY096-OAP | GM1a Ganglioside oligosaccharide-β-aminopropyl (>90%) (Sodium salt) | 5mg | 40485.5 |
elicityl-oligotech | GLY093-NPR | GM2 Ganglioside oligosaccharide-NAc-propargyl | 5mg | 40485.5 |
elicityl-oligotech | GLY034-OAP | Blood group A antigen triaose-β-O-aminopropyl | 25mg | 38054.5 |
elicityl-oligotech | GLY050-90% | Lewis x (LeX) tetraose (>90% NMR) | 100mg | 38054.5 |
elicityl-oligotech | GLY058-AP | Blood group B antigen triaose-β-O-aminopropyl | 25mg | 38054.5 |
elicityl-oligotech | GLY095-80% | GT2 Ganglioside oligosaccharide (>80%) (Sodium salt) | 25mg | 40766 |
elicityl-oligotech | GLY100-80% | GT1a Ganglioside oligosaccharide (>80%) (Sodium salt) | 25mg | 40766 |
elicityl-oligotech | GLY120-NAc-sp1-NH2 | Globotriaose (Gb3)-NAc-CH2-(1.4-Tz)-(CH2)2-EG3-NH2 | 5mg | 38802.5 |
elicityl-oligotech | ALG542 | Manuronate oligosaccharide DP2 (sodium salt) | 100mg | 39083 |
elicityl-oligotech | ALG543 | Manuronate oligosaccharide DP3 (sodium salt) | 100mg | 39083 |
elicityl-oligotech | ALG544 | Manuronate oligosaccharide DP4 (sodium salt) | 100mg | 39083 |
elicityl-oligotech | GLY104-90% | aGM2 (asialo GM2) Ganglioside oligosaccharide / GA2 (>90% NMR) (Sodium salt) | 100mg | 39270 |
elicityl-oligotech | ALG342 | Guluronate oligosaccharides DP2 (sodium salt) | 100mg | 42075 |
elicityl-oligotech | ALG343 | Guluronate oligosaccharides DP3 (sodium salt) | 100mg | 42075 |
elicityl-oligotech | ALG344 | Guluronate oligosaccharides DP4 (sodium salt) | 100mg | 42075 |
elicityl-oligotech | GLY094-NAc-sp1-NH2 | GD2 Ganglioside oligosaccharide-NAc-CH2-(1.4-Tz)-(CH2)2-EG3-NH2 | 1mg | 42262 |
elicityl-oligotech | GLY056-NAc-sp3-Bt | Lewis b (Le b) pentaose-O-CH2-(1.4-Tz)-(CH2)2-EG3-NH-Biotin | 1mg | 39644 |
elicityl-oligotech | GLY131-NAc-sp3-Bt | SSEA-4 hexaose-Biotin | 1mg | 39737.5 |
elicityl-oligotech | GLY010-90% | Lacto-N-tetraose (LNT) (>90% NMR) | 500mg | 39924.5 |
elicityl-oligotech | GLY031-3-99% | Blood group H antigen triaose type 5 / 2’Fucosyllactose / 2'FL (>99% HPLC) | 1000mg | 40018 |
elicityl-oligotech | GLY011-BSA | Lacto-N-Triaose (LNT2) linked on BSA | 5mg | 40111.5 |
elicityl-oligotech | GLY021-BSA | Lacto-N-neotetraose linked to BSA | 5mg | 40111.5 |
elicityl-oligotech | GLY022-BSA | Para-Lacto-N-neohexaose linked to BSA | 5mg | 40111.5 |
elicityl-oligotech | GLY033-2-BSA | Blood group H antigen pentaose type 2 linked to BSA | 5mg | 40111.5 |
elicityl-oligotech | GLY035-3-BSA | Blood group A antigen tetraose type 5 linked to BSA | 5mg | 40111.5 |
elicityl-oligotech | GLY037-1-BSA | Blood group A antigen hexaose type 1 linked to BSA | 5mg | 40111.5 |
elicityl-oligotech | GLY037-2-BSA | Blood group A antigen hexaose type 2 linked to BSA | 5mg | 40111.5 |
elicityl-oligotech | GLY038-3-BSA | Blood group B antigen tetraose type 5 linked to BSA | 5mg | 40111.5 |
elicityl-oligotech | GLY040-1-BSA | Blood group B antigen hexaose type 1 linked to BSA | 5mg | 40111.5 |
elicityl-oligotech | GLY040-2-BSA | Blood group B antigen hexaose type 2 linked to BSA | 5mg | 40111.5 |
elicityl-oligotech | GLY054-BSA | Lewis a tetraose linked to BSA | 5mg | 40111.5 |
elicityl-oligotech | GLY055-BSA | Lewis a hexaose (LNDFH II) linked to BSA | 5mg | 40111.5 |
elicityl-oligotech | GLY064-BSA | α-3Galactosyl-3Fucosyllactose linked to BSA | 5mg | 40111.5 |
elicityl-oligotech | GLY067-BSA | 3-Fucosylated Blood group A tetraose linked to BSA | 5mg | 40111.5 |
elicityl-oligotech | GLY068-BSA | 3-Fucosylated Blood group B tetraose linked to BSA | 5mg | 40111.5 |
elicityl-oligotech | GLY070-BSA | Isoglobotriaose (IsoGb3) linked to BSA | 5mg | 40111.5 |
elicityl-oligotech | GLY072-BSA | Isoglobotetraose (Cytolipin R) linked to BSA | 5mg | 40111.5 |
elicityl-oligotech | GLY073-BSA | Isoglobopentaose (iGb5) linked to BSA | 5mg | 40111.5 |
elicityl-oligotech | GLY120-BSA | Globotriaose (Gb3) / Pk antigen linked to BSA | 5mg | 40111.5 |
elicityl-oligotech | GLY121-BSA | Globotetraose (Gb4) / P antigen linked to BSA | 5mg | 40111.5 |
elicityl-oligotech | GLY124-BSA | Globo-A heptaose linked to BSA | 5mg | 40111.5 |
elicityl-oligotech | GLY125-BSA | Globo-B heptaose linked to BSA | 5mg | 40111.5 |
elicityl-oligotech | GLY134-BSA | Isoforssman antigen pentaose linked to BSA | 5mg | 40111.5 |
elicityl-oligotech | GLY090-NAc-sp3-Bt | 3'-Sialyllactose-NAc-CH2-(1.4-Tz)-(CH2)2-EG3-NH-Biotin | 1mg | 43010 |
elicityl-oligotech | GLY096-NAc-sp3-Bt | GM1a Ganglioside oligosaccharide - Biotin | 1mg | 43010 |
elicityl-oligotech | GLY060-90% | 3 Fucosyllactose / 3-FL (>90% NMR) | 500mg | 40298.5 |
elicityl-oligotech | GLY096-90% | GM1a Ganglioside oligosaccharide (>90%) (Sodium salt) | 100mg | 43384 |
elicityl-oligotech | GLY039-2-90% | Blood group B antigen pentaose type 2 (>90% NMR) | 25mg | 40672.5 |
elicityl-oligotech | GLY051-75% | Lewis x (LeX) hexaose / Lacto-N-neodifucohexaose (LNnDFH) (>75% NMR) | 25mg | 40672.5 |
elicityl-oligotech | GLY251 | Galα1-4Galα1-4Galα1-4Galβ1-4Glc/ Galα1-4Galα1-4Gb3 | 25mg | 40672.5 |
elicityl-oligotech | GLY051-90% | Lewis x (LeX) hexaose / Lacto-N-neodifucohexaose (LNnDFH) (>90% NMR) | 25mg | 40672.5 |
elicityl-oligotech | GLU1111 | Reduced XFG xyloglucan oligosaccharide (DP7) XFGol | 1000mg | 40766 |
elicityl-oligotech | GLY036-1-80% | Blood group A antigen pentaose type 1 (>80% NMR) | 25mg | 40766 |
elicityl-oligotech | GLY066-90% | Lactodifucotetraose / Difucosyllactose / DF-L (>90% NMR) | 25mg | 40766 |
elicityl-oligotech | GLY101-80% | GT1c Ganglioside oligosaccharide (>80% NMR) (Sodium salt) | 25mg | 40766 |
elicityl-oligotech | GLU437 | Chitin oligosaccharides DP7 / chitinheptaose | 10mg | 40859.5 |
elicityl-oligotech | GLY226-AP | Glucose-β-Aminopropyl | 100mg | 41140 |
elicityl-oligotech | GLU1110 | XFG xyloglucan oligosaccharide (DP7) | 100mg | 41420.5 |
elicityl-oligotech | GLU1160 | XLFG xyloglucan oligosaccharide (DP10) | 100mg | 41420.5 |
elicityl-oligotech | GLU423 | Chitosan oligosaccharide - average DP40 | 1000mg | 41514 |
elicityl-oligotech | GLY160 | Galactosyl-lactose | 100mg | 42075 |
elicityl-oligotech | GLY161-90% | Difucosylpentaose | 100mg | 42075 |
elicityl-oligotech | GLY162 | Disialosylpentaose | 100mg | 42075 |
elicityl-oligotech | GLY121-90% | Globotetraose (Gb4) / P antigen (>90% NMR) | 100mg | 42168.5 |
elicityl-oligotech | ALG320 | Guluronate oligosaccharides average DP5 (sodium salt) | 500mg | 45254 |
elicityl-oligotech | GLY033-1-NAc-sp3-Bt | Blood group H antigen pentaose type 1-NAc-CH2-(1.4-Tz)-(CH2)2-EG3-NH-Biotin | 1mg | 43010 |
elicityl-oligotech | GLY037-1-NAc-Sp3-Bt | Blood group A antigen hexaose type 1-NAc-CH2-(1.4-Tz)-(CH2)2-EG3-NH-Biotin | 1mg | 43010 |
elicityl-oligotech | GLY040-1-NAc-sp3-Bt | Blood group B antigen hexaose type 1-NAc-CH2-(1.4-Tz)-(CH2)2-EG3-NH-Biotin | 1mg | 43010 |
elicityl-oligotech | GLY052-NAc-sp3-Bt | Lewis y (LeY) pentaose-NAc-CH2-(1.4-Tz)-(CH2)2-EG3-NH-Biotin | 1mg | 43010 |
elicityl-oligotech | GLY103-NAc-sp3-Bt | Fucosyl GM1 Ganglioside oligosaccharide - Biotin | 1mg | 43010 |
elicityl-oligotech | GLY010-95% | Lacto-N-tetraose (LNT) (>95% HPLC) | 500mg | 43103.5 |
elicityl-oligotech | GLY031-3-13C labelled | 2'FL labelled 13C | 100mg | 43197 |
elicityl-oligotech | REF021 | Lacto-N-neotetraose (LNnT / neo-LNT) Analytical Reference | 50mg | 43197 |
elicityl-oligotech | GLU304-98% | Cellohexaose (>98% HPAEC-PAD) | 100mg | 43384 |
elicityl-oligotech | GLY011-90% | Lacto-N-Triaose (LNT2) (>90% NMR) | 75mg | 43384 |
elicityl-oligotech | GLY023-90% | Lacto-N-neooctaose (LNnO) (>90%) | 25mg | 43384 |
elicityl-oligotech | GLY083-90% | LS-Tetrasaccharide d (LSTd) / Sialyl-lacto-N-neotetraose d (>90% NMR) (Sodium salt) | 100mg | 43384 |
elicityl-oligotech | GLY007-90% | Di-N-Acetyl-D-Lactosamine (>90% NMR) | 100mg | 43477.5 |
elicityl-oligotech | GLY024-90% | Galacto-N-Neopentaose Di LAcNac Gal (>90% NMR) | 100mg | 43477.5 |
elicityl-oligotech | GLY038-3-90% | Blood group B antigen tetraose type 5 (>90% NMR) | 100mg | 43477.5 |
elicityl-oligotech | GLY054-90% | Lewis a (Lea) tetraose (>90% NMR) | 100mg | 43477.5 |
elicityl-oligotech | GLY055-90% | Lewis a (Le a) hexaose / Lacto-N-difucohexaose II (LNDFH II) (>90% NMR) | 100mg | 43477.5 |
elicityl-oligotech | GLY056-90% | Lewis b (Le b) pentaose (>90% NMR) | 100mg | 43477.5 |
elicityl-oligotech | GLY060-95% | 3 Fucosyllactose (3-FL) (>95% NMR) | 500mg | 43477.5 |
elicityl-oligotech | GLY126-90% | Core type 4 (Gb5 triaose core structure) | 100mg | 43477.5 |
elicityl-oligotech | GLY151-95% | GalNAcβ1-3Gal / Gb4 Globoside terminal | 100mg | 43477.5 |
elicityl-oligotech | ULV102 | Ulvan polysaccharides from Ulva sp. Fine grade | 1000mg | 43758 |
elicityl-oligotech | ULV103 | Ulvan polysaccharides from Enteromorpha sp. Fine grade | 1000mg | 43758 |
elicityl-oligotech | GLU320-98% | Maltodecaose DP10 (>98% HPLC) | 100mg | 44412.5 |
elicityl-oligotech | GLY009-95% | Lacto-N-Biose (>95% HPLC) | 100mg | 45160.5 |
elicityl-oligotech | GLY048-70% | Lewis Y (LeY) tetraose (>70% NMR) | 100mg | 45254 |
elicityl-oligotech | GLY048-90% | Lewis Y (LeY) tetraose (>90% NMR) | 100mg | 45254 |
elicityl-oligotech | GLY094-NAc-sp3-DBt | GD2 Ganglioside oligosaccharide - Desthiobiotin | 1mg | 48713.5 |
elicityl-oligotech | GLY099-80% | GD1b Ganglioside oligosaccharide (>80%) (Sodium salt) | 25mg | 48900.5 |
elicityl-oligotech | GLY099-90% | GD1b Ganglioside oligosaccharide (>90%) (Sodium salt) | 25mg | 48900.5 |
elicityl-oligotech | GLY099-50% | GD1b Ganglioside oligosaccharide (>50%) (Sodium salt) | 25mg | 48900.5 |
elicityl-oligotech | GLY100-90% | GT1a Ganglioside oligosaccharide (>90%) (Sodium salt) | 25mg | 48900.5 |
elicityl-oligotech | GLY095-90% | GT2 Ganglioside oligosaccharide (>90%) (Sodium salt) | 25mg | 48900.5 |
elicityl-oligotech | GLY094-90% | GD2 Ganglioside oligosaccharide (>90%) (Sodium salt) | 25mg | 48900.5 |
elicityl-oligotech | GLY098-90% | GD1a Ganglioside oligosaccharide (>90%) (Sodium salt) | 25mg | 48900.5 |
elicityl-oligotech | GLY092-NAc-sp3-Bt | GT3 Ganglioside oligosaccharide -NAc-CH2-(1.4-Tz)-(CH2)2-EG3-NH-Biotin | 1mg | 49368 |
elicityl-oligotech | GLY091-NAc-sp3-Bt | GD3 Ganglioside oligosaccharide -NAc-CH2-(1.4-Tz)-(CH2)2-EG3-NH-Biotin | 1mg | 49368 |
elicityl-oligotech | GLY094-NAc-sp3-Bt | GD2 Ganglioside oligosaccharide - Biotin | 1mg | 49368 |
elicityl-oligotech | GLY093-NAc-sp3-Bt | GM2 Ganglioside oligosaccharide - Biotin | 1mg | 49368 |
elicityl-oligotech | GLY098-NAc-sp3-Bt | GD1a Ganglioside oligosaccharide - Biotin | 1mg | 49368 |
elicityl-oligotech | GLY036-1-85% | Blood group A antigen pentaose type 1 (>85% NMR) | 25mg | 46282.5 |
elicityl-oligotech | GLY010-90% | Lacto-N-tetraose (LNT) (>90% NMR) | 1000mg | 46376 |
elicityl-oligotech | GLY082-85% | Sialylated tetraose type 2 (Sodium salt) (>85% NMR) | 25mg | 46376 |
elicityl-oligotech | GLY074-2-90% | Xeno antigen type 2 / Galili antigen triaose / Galα -3 epitope/Linear B-2 trisaccharide (>90% NMR) | 100mg | 46469.5 |
elicityl-oligotech | FUC100 | Fucoidan polysaccharide from Fucus vesiculosus | 1000mg | 46843.5 |
elicityl-oligotech | GLY023-95% | Lacto-N-neooctaose (LNnO) (>95% HPLC) | 25mg | 46843.5 |
elicityl-oligotech | GLY011-95% | Lacto-N-Triaose (LNT2) (>95% HPLC) | 75mg | 46937 |
elicityl-oligotech | GLU301-90% | Cellotriose (>90% HPAEC-PAD) | 1000mg | 47498 |
elicityl-oligotech | GLY122-90% | Globopentaose (Gb5) / Stage Specific Embryonic Antigen 3a (SSEA-3a) (>90% NMR) | 100mg | 47498 |
elicityl-oligotech | GLY096-95% | GM1a Ganglioside oligosaccharide (>95%) (Sodium salt) | 100mg | 50957.5 |
elicityl-oligotech | GLY122-BSA | Globopentaose (Gb5) linked to BSA | 5mg | 48152.5 |
elicityl-oligotech | GLY123-BSA | Globo-H hexaose (SSEA-3b) linked to BSA | 5mg | 48152.5 |
elicityl-oligotech | GLY131-BSA | SSEA-4 hexaose - BSA | 5mg | 48152.5 |
elicityl-oligotech | GLY132-BSA | Forssman antigen pentaose linked to BSA | 5mg | 48152.5 |
elicityl-oligotech | GLY066-95% | Lactodifucotetraose / Difucosyllactose / DF-L (>95% NMR) | 25mg | 48713.5 |
elicityl-oligotech | GLY036-1-90% | Blood group A antigen pentaose type 1 (>90% NMR) | 25mg | 48900.5 |
elicityl-oligotech | GLY036-2-90% | Blood group A antigen pentaose type 2 (>90% NMR) | 25mg | 48900.5 |
elicityl-oligotech | GLY039-1-90% | Blood group B antigen pentaose type 1 (>90% NMR) | 25mg | 48900.5 |
elicityl-oligotech | GLY061-90% | Lacto-N-neofucopentaose / LNnFP-V/LNFP VI | 25mg | 48900.5 |
elicityl-oligotech | GLY071-90% | Galili antigen pentaose (>90% NMR) | 25mg | 48900.5 |
elicityl-oligotech | GLY101-90% | GT1c Ganglioside oligosaccharide (>90% NMR) (Sodium salt) | 25mg | 48900.5 |
elicityl-oligotech | GLY131-90% | SSEA-4 hexaose / Stage-Specific Embryonic Antigen-4 hexaose (>90% NMR) | 25mg | 48900.5 |
elicityl-oligotech | GLY154-90% | α1-4 galactobiose / Galα1-4Gal (>90% NMR) | 100mg | 48900.5 |
elicityl-oligotech | GLY171-85% | Sialylated globotriose/ 3Sialyl-Gb3 | 25mg | 48900.5 |
elicityl-oligotech | GLY172-85% | Disialylated pentaose type 1 | 25mg | 48900.5 |
elicityl-oligotech | GLY174-90% | GalGalNac-aGM1 (GalGalNAc asialo GM1) Ganglioside oligosaccharide analogue | 25mg | 48900.5 |
elicityl-oligotech | MAN802 | Mannan polysaccharide from Yeast | 10000mg | 49368 |
elicityl-oligotech | GLY010-95% | Lacto-N-tetraose (LNT) (>95% HPLC) | 1000mg | 50116 |
elicityl-oligotech | GLY023-98% | Lacto-N-neooctaose (LNnO) (>98% HPLC) | 25mg | 50583.5 |
elicityl-oligotech | GLY094-95% | GD2 Ganglioside oligosaccharide (>95%) (Sodium salt) | 25mg | 54697.5 |
elicityl-oligotech | GAT114 | Galacturonan oligosaccharides Mixture DP10/DP15 | 2000mg | 51425 |
elicityl-oligotech | LEC101 | LecB (PA-IIL) from Pseudomonas aeruginosa - (Bacterial protein produced in E. coli) | 10mg | 51425 |
elicityl-oligotech | LEC102 | LecA (PA-IL) from Pseudomonas aeruginosa - (Bacterial protein produced in E. coli) | 10mg | 51425 |
elicityl-oligotech | GLY081-85% | LS-Tetrasaccharide a (LSTa) / Sialyl-lacto-N-tetraose a (>85% NMR) (Sodium salt) | 100mg | 52079.5 |
elicityl-oligotech | LEC401 | DC-SIGN ECD (extra-cellular domain) - (Human protein produced in E. coli) | 1mg | 52079.5 |
elicityl-oligotech | GAT300 | Rhamnogalacturonan polysaccharide from gombo/okra (sodium salt)) | 1000mg | 52453.5 |
elicityl-oligotech | GLY040-1-NAc-sp1-NH2 | Blood group B antigen hexaose type 1-NAc-CH2-(1.4-Tz)-(CH2)2-EG3-NH2 | 10mg | 52827.5 |
elicityl-oligotech | GLY040-1-NAc-sp2-NH2 | Blood group B antigen hexaose type 1-NAc-CH2-(1.4-Tz)-(CH2)2-EG7-NH2 | 10mg | 52827.5 |
elicityl-oligotech | GLY050-NAc-sp1-NH2 | Lewis X tetraose-NAc-CH2-(1.4-Tz)-(CH2)2-EG3-NH2 | 10mg | 52827.5 |
elicityl-oligotech | GLY052-NAc-sp1-NH2 | Lewis y pentaose-NAc-CH2-(1.4-Tz)-(CH2)2-EG3-NH2 | 10mg | 52827.5 |
elicityl-oligotech | GLY054-NAc-sp1-NH2 | Lewis a tetraose-NAc-CH2-(1.4-Tz)-(CH2)2-EG3-NH2 | 10mg | 52827.5 |
elicityl-oligotech | GLY084-2-90% | Sialylated triaose type 2/ 3'-α-sialyl-Acetyl-Lactosamine/ sialyl Lex precursor (>90% NMR) (Sodium salt) | 100mg | 53108 |
elicityl-oligotech | REF066 | Difucosyllactose (DF-L) Analytical Reference | 10mg | 53482 |
elicityl-oligotech | GLY092-80% | GT3 Ganglioside oligosaccharide (>80%) (Sodium salt) | 100mg | 57876.5 |
elicityl-oligotech | GLY052-90% | Lewis y (LeY) pentaose (>90% NMR) | 100mg | 54323.5 |
elicityl-oligotech | GLY077-90% | Galili antigen heptaose (>90% NMR) | 25mg | 54323.5 |
elicityl-oligotech | GLY074-2-90% | Xeno antigen type 2 / Galili antigen triaose / Galα -3 epitope/Linear B-2 trisaccharide (>90% NMR) | 250mg | 54510.5 |
elicityl-oligotech | GLY078-85% | Galili antigen nonaose (>85% NMR) | 25mg | 55258.5 |
elicityl-oligotech | REF010 | Lacto-N-tetraose (LNT) Analytical Reference | 50mg | 55539 |
elicityl-oligotech | FRU130-95% | Fructo-Oligosaccharides Kit 10 mg DP3 to DP10 (>95% HPAEC-PAD) | 10mg | 57128.5 |
elicityl-oligotech | GLY060-90% | 3 Fucosyllactose / 3-FL (>90% NMR) | 1000mg | 57222 |
elicityl-oligotech | GLY131-NAc-sp1-NH2 | SSEA-4 hexaose-NAc-CH2-(1.4-Tz)-(CH2)2-EG3-NH2 | 5mg | 57970 |
elicityl-oligotech | GLY011-90% | Lacto-N-Triaose (LNT2) (>90% NMR) | 100mg | 58624.5 |
elicityl-oligotech | XYL101 | Glucurono-Arabinoxylan PLS from wheat bran | 5000mg | 58624.5 |
elicityl-oligotech | ALG310 | Guluronate oligosaccharides average DP10 (sodium salt) | 1000mg | 62738.5 |
elicityl-oligotech | ALG510 | Mannuronate oligosaccharides Average DP10 (sodium salt) | 1000mg | 62738.5 |
elicityl-oligotech | GLY078-90% | Galili antigen nonaose (>90% NMR) | 25mg | 59746.5 |
elicityl-oligotech | GLY066-90% | Lactodifucotetraose / Difucosyllactose / DF-L (>90% NMR) | 50mg | 60027 |
elicityl-oligotech | LEC302 | BC2LC-Nt from Burkholderia cenocepacia - (Bacterial protein produced in E. coli) | 5mg | 60307.5 |
elicityl-oligotech | GLY032-1-90% | Blood group H antigen tetraose type 1 (>90% NMR) | 100mg | 60868.5 |
elicityl-oligotech | GLY037-1-90% | Blood group A antigen hexaose type 1 (>90% NMR) | 100mg | 60868.5 |
elicityl-oligotech | GLY037-2-90% | Blood group A antigen hexaose type 2 (>90% NMR) | 100mg | 60868.5 |
elicityl-oligotech | GLY040-1-90% | Blood group B antigen hexaose type 1 (>90% NMR) | 100mg | 60868.5 |
elicityl-oligotech | GLY040-2-90% | Blood group B antigen hexaose type 2 (>90% NMR) | 100mg | 60868.5 |
elicityl-oligotech | GLY081-90% | LS-Tetrasaccharide a (LSTa) / Sialyl-lacto-N-tetraose a (>90% NMR) (Sodium salt) | 100mg | 60868.5 |
elicityl-oligotech | GLY128-90% | Blood group A antigen pentaose type 4 (>90% NMR) | 100mg | 60868.5 |
elicityl-oligotech | GLY129-85% | Blood group B antigen pentasaccharide type 4 (>85% NMR) | 100mg | 60868.5 |
elicityl-oligotech | GLY129-90% | Blood group B antigen pentasaccharide type 4 (>90% NMR) | 100mg | 60868.5 |
elicityl-oligotech | GLY226-AP | Glucose-β-Aminopropyl | 1000mg | 61710 |
elicityl-oligotech | GAT102 | Galacturonate polysaccharides LM from citrus (sodium salt) | 10000mg | 61803.5 |
elicityl-oligotech | FRU116-90% | Fructo-oligosaccharide DP10 / GF9 (>90% HPAEC-PAD) | 100mg | 62084 |
elicityl-oligotech | GLY074-2-95% | Xeno antigen type 2 / Galili antigen triaose / Galα -3 epitope/Linear B-2 trisaccharide (>95% NMR) | 250mg | 62738.5 |
elicityl-oligotech | GLY011-95% | Lacto-N-Triaose (LNT2) (>95% HPLC) | 100mg | 63393 |
elicityl-oligotech | GLU435-90% | Chitin oligosaccharides DP5 / chitinpentaose (>90% RMN) | 250mg | 63486.5 |
elicityl-oligotech | GLY077-95% | Galili antigen heptaose (>95% NMR) | 25mg | 63580 |
elicityl-oligotech | LEC202 | RSL from Ralstonia solanacearum - (Bacterial protein produced in E. coli) | 10mg | 63580 |
elicityl-oligotech | LEC301 | BC2LA from Burkholderia cenocepacia - (Bacterial protein produced in E. coli) | 10mg | 63580 |
elicityl-oligotech | GLY051-BSA | Lewis x hexaose (LNnDFH) linked to BSA | 5mg | 64141 |
elicityl-oligotech | GLY066-BSA | Lactodifucotetraose (DF-L) linked to BSA | 5mg | 64141 |
elicityl-oligotech | GLY071-BSA | Galili antigen pentaose linked to BSA | 5mg | 64141 |
elicityl-oligotech | GLY077-BSA | Galili antigen heptaose linked to BSA | 5mg | 64141 |
elicityl-oligotech | GLY094-NPR | GD2 Ganglioside oligosaccharide-β-NAc-propargyl | 5mg | 68909.5 |
elicityl-oligotech | ALG320 | Guluronate oligosaccharides average DP5 (sodium salt) | 1000mg | 68909.5 |
elicityl-oligotech | ALG520 | Mannuronate oligosaccharides Average DP5 (sodium salt) | 1000mg | 68909.5 |
elicityl-oligotech | GLY092-90% | GT3 Ganglioside oligosaccharide (>90%) (Sodium salt) | 100mg | 69470.5 |
elicityl-oligotech | GLY091-90% | GD3 Ganglioside oligosaccharide / Disialyl lactose/ DS-L (>90%) (Sodium salt) | 100mg | 69470.5 |
elicityl-oligotech | GLY093-90% | GM2 Ganglioside oligosaccharide (>90%) (Sodium salt) | 100mg | 69470.5 |
elicityl-oligotech | GLY097-90% | GM1b Ganglioside oligosaccharide (>90%) (Sodium salt) | 100mg | 69470.5 |
elicityl-oligotech | GLY034-90% | Blood group A antigen triaose | 100mg | 65169.5 |
elicityl-oligotech | GLY091-NAc-sp1-NH2 | GD3 Ganglioside oligosaccharide -NAc-CH2-(1.4-Tz)-(CH2)2-EG3-NH2 | 5mg | 69938 |
elicityl-oligotech | GLY123-NPR | Globo-H-β-NAc-propargyl / SSEA3b-β-NAc-propargyl | 10mg | 65543.5 |
elicityl-oligotech | ALG300 | Guluronate oligosaccharides average DP20 (sodium salt) | 5000mg | 70592.5 |
elicityl-oligotech | GLY064-60% | α-3Galactosyl-3Fucosyllactose (>60% NMR) | 100mg | 66011 |
elicityl-oligotech | GLY123-NAc-sp1-NH2-90% | Globo-H hexaose (SSEA-3b)-NAc-CH2-(1.4-Tz)-(CH2)2-EG3-NH2 (>90% NMR) | 5mg | 66478.5 |
elicityl-oligotech | GLY022-90% | Para-Lacto-N-neohexaose (Para-LNnH) (>90% NMR) | 100mg | 67881 |
elicityl-oligotech | GLY079-90% | Galili antigen undecaose (>90% NMR) | 25mg | 67881 |
elicityl-oligotech | GLY094-NAc-sp3-DBt | GD2 Ganglioside oligosaccharide - Desthiobiotin | 2mg | 73397.5 |
elicityl-oligotech | GAT111 | Galacturonan oligosaccharides Mixture DP3/DP4 | 1000mg | 68909.5 |
elicityl-oligotech | GLY021-90% | Lacto-N-neotetraose (LNnT / neo-LNT) | 1000mg | 68909.5 |
elicityl-oligotech | GLY089-85% | 2,6'-Sialyllactose (6'SL) (85% NMR) | 5000mg | 68909.5 |
elicityl-oligotech | ALG500 | Mannuronate oligosaccharides Average DP20 (sodium salt) | 5000mg | 74052 |
elicityl-oligotech | GLY012-90% | Para-Lacto-N-hexaose (Para-LNH) | 100mg | 69283.5 |
elicityl-oligotech | GLY005-90% | Core type 1 triaose | 100mg | 69470.5 |
elicityl-oligotech | GLY006-90% | Core type 2 triaose | 100mg | 69470.5 |
elicityl-oligotech | GLY031-1-70% | Blood group H antigen triaose type 1 (>70% NMR) | 100mg | 69470.5 |
elicityl-oligotech | GLY031-1-80% | Blood group H antigen triaose type 1 (>80% NMR) | 100mg | 69470.5 |
elicityl-oligotech | GLY031-1-90% | Blood group H antigen triaose type 1 (>90% NMR) | 100mg | 69470.5 |
elicityl-oligotech | GLY031-1-95% | Blood group H antigen triaose type 1 (>95% NMR) | 100mg | 69470.5 |
elicityl-oligotech | GLY033-2-90% | Blood group H antigen pentaose type 2 / Lacto-N-neofucopentaose I (LnNFP I) (>90% NMR) | 100mg | 69470.5 |
elicityl-oligotech | GLY035-1-90% | Blood group A antigen tetraose type 1 (>90% NMR) | 100mg | 69470.5 |
elicityl-oligotech | GLY035-2-90% | Blood group A antigen tetraose type 2 | 100mg | 69470.5 |
elicityl-oligotech | GLY035-4-90% | Blood group A Lewisb antigen pentaose type 1 | 100mg | 69470.5 |
elicityl-oligotech | GLY035-5-85% | Blood group A LewisY antigen pentaose type 2 | 100mg | 69470.5 |
elicityl-oligotech | GLY038-1-90% | Blood group B antigen tetraose type 1 (>90% NMR) | 100mg | 69470.5 |
elicityl-oligotech | GLY038-2-90% | Blood group B antigen tetraose type 2 (>90% NMR) | 100mg | 69470.5 |
elicityl-oligotech | GLY038-4-90% | Blood group B Lewisb antigen pentaose type 1 (>90% NMR) | 100mg | 69470.5 |
elicityl-oligotech | GLY038-5-90% | Blood group B LewisY antigen pentaose type 2 | 100mg | 69470.5 |
elicityl-oligotech | GLY063 | 3’Sialyl-3Fucosyllactose / F-SL (Sodium salt) | 100mg | 69470.5 |
elicityl-oligotech | GLY067-70% | 3-Fucosylated Blood group A tetraose | 100mg | 69470.5 |
elicityl-oligotech | GLY068 | 3-Fucosylated Blood group B tetraose | 100mg | 69470.5 |
elicityl-oligotech | GLY072-90% | Isoglobotetraose / iGb4 / Cytolipin R (>90% NMR) | 100mg | 69470.5 |
elicityl-oligotech | GLY073-90% | Isoglobopentaose / iGb5 | 100mg | 69470.5 |
elicityl-oligotech | GLY103-90% | Fucosyl GM1 Ganglioside oligosaccharide (>90% NMR) (Sodium salt) | 100mg | 69470.5 |
elicityl-oligotech | GLY111-80% | GM2 Ganglioside oligosaccharide analogue (>80% NMR) (Sodium salt) | 100mg | 69470.5 |
elicityl-oligotech | GLY111-90% | GM2 Ganglioside oligosaccharide analogue (>90% NMR) (Sodium salt) | 100mg | 69470.5 |
elicityl-oligotech | GLY123-90% | Globo-H hexaose / Stage Specific Embryonic Antigen 3b (SSEA-3b) (>90% NMR) | 100mg | 69470.5 |
elicityl-oligotech | GLY124-90% | Globo-A heptaose | 100mg | 69470.5 |
elicityl-oligotech | GLY125-90% | Globo-B heptaose (>90% NMR) | 100mg | 69470.5 |
elicityl-oligotech | GLY127-90% | Blood group H antigen tetraose type 4 / Globo H tetraose -NAc-CH2-(1.4-Tz)-(CH2)2-EG3-NH2 | 100mg | 69470.5 |
elicityl-oligotech | GLY130-85% | SSEA-4 tetraose / Stage-Specific Embryonic Antigen-4 tetraose | 100mg | 69470.5 |
elicityl-oligotech | GLY132-90% | Forssman antigen pentaose | 100mg | 69470.5 |
elicityl-oligotech | GLY133-90% | Forssman antigen triaose | 100mg | 69470.5 |
elicityl-oligotech | GLY134-90% | Isoforssman antigen pentaose | 100mg | 69470.5 |
elicityl-oligotech | GLY164 | Fucosylated A antigen type 5 | 100mg | 69470.5 |
elicityl-oligotech | GLY165-80% | Fucosylated B antigen type 5 (>80% NMR) | 100mg | 69470.5 |
elicityl-oligotech | GLY165-90% | Fucosylated B antigen type 5 (>90% NMR) | 100mg | 69470.5 |
elicityl-oligotech | GLY181-90% | Glucuronyl-LNT / Glucuronyl-Lacto-N-tetraose (>90% NMR) (Sodium salt) | 100mg | 69470.5 |
elicityl-oligotech | GLY190 | Globotetraose analogue / Gb4 analogue | 100mg | 69470.5 |
elicityl-oligotech | GLY191-1-90% | Globopentaose analogue type 1 / Gb5 analogue type 1 | 100mg | 69470.5 |
elicityl-oligotech | GLY191-2-90% | Globopentaose analogue type 2 / Gb5 analogue type 2 | 100mg | 69470.5 |
elicityl-oligotech | GLY194-1 | Globo-H analogue type 1 | 100mg | 69470.5 |
elicityl-oligotech | GLY194-2-90% | Globo-H analogue type 2 | 100mg | 69470.5 |
elicityl-oligotech | GLY195-1 | SSEA-4 hexaose analogue type 1 | 100mg | 69470.5 |
elicityl-oligotech | GLY195-2 | SSEA-4 hexaose analogue type 2 | 100mg | 69470.5 |
elicityl-oligotech | GLY196-1-75% | Sialylated-SSEA-4 hexaose analogue type 1 | 100mg | 69470.5 |
elicityl-oligotech | GLY197 | Isoglobotetraose analogue / iGb4 analogue | 100mg | 69470.5 |
elicityl-oligotech | GLY198-1 | Isoglobopentaose analogue type 1 / iGb5 analogue type 1 | 100mg | 69470.5 |
elicityl-oligotech | GLY201-1 | Isoglobo-H analogue type 1 | 100mg | 69470.5 |
elicityl-oligotech | GLY201-2 | Isoglobo-H analogue type 2 | 100mg | 69470.5 |
elicityl-oligotech | GLY202-1 | Sialylated isoglobopentaose analogue type 1 / Sialylated iGb5 analogue type 1 | 100mg | 69470.5 |
elicityl-oligotech | GLY202-2 | Sialylated isoglobopentaose analogue type 2 / Sialylated iGb5 analogue type 2 | 100mg | 69470.5 |
elicityl-oligotech | GLY250-80% | Galα1-4Galα1-4Galβ1-4Glc / Galα1-4Gb3 (> 80% NMR) | 100mg | 69470.5 |
elicityl-oligotech | GLY163-80% | 2'2 Difucosyllactose (>80% NMR) | 100mg | 69564 |
elicityl-oligotech | GLY093-NAc-sp1-NH2 | GM2 Ganglioside oligosaccharide-NAc-CH2-(1.4-Tz)-(CH2)2-EG3-NH2 (Sodium salt) | 5mg | 75080.5 |
elicityl-oligotech | GLY096-OAP | GM1a Ganglioside oligosaccharide-β-aminopropyl (>90%) (Sodium salt) | 25mg | 76015.5 |
elicityl-oligotech | GLY098-NPR | GD1a Ganglioside oligosaccharide-β-NAc-propargyl (Sodium salt) | 25mg | 76015.5 |
elicityl-oligotech | GLY094-NPR | GD2 Ganglioside oligosaccharide-β-NAc-propargyl | 25mg | 76015.5 |
elicityl-oligotech | GLY089-95% | 2,6'-Sialyllactose (6'SL) (95% NMR) | 5000mg | 71527.5 |
elicityl-oligotech | GLY066-95% | Lactodifucotetraose / Difucosyllactose / DF-L (>95% NMR) | 50mg | 71995 |
elicityl-oligotech | GLY051-75% | Lewis x (LeX) hexaose / Lacto-N-neodifucohexaose (LNnDFH) (>75% NMR) | 100mg | 73023.5 |
elicityl-oligotech | GLY051-90% | Lewis x (LeX) hexaose / Lacto-N-neodifucohexaose (LNnDFH) (>90% NMR) | 100mg | 73023.5 |
elicityl-oligotech | GLY078-BSA | Galili antigen nonaose linked to BSA | 5mg | 74052 |
elicityl-oligotech | GLY021-95% | Lacto-N-neotetraose (LNnT / neo-LNT) (>95% HPLC) | 1000mg | 74426 |
elicityl-oligotech | GLY062-80% | Lacto-N-fucopentaose V / LNFP V (>80% NMR) | 100mg | 75080.5 |
elicityl-oligotech | GLY090-NAc-sp1-NH2 | 3'-Sialyllactose-NAc-CH2-(1.4-Tz)-(CH2)2-EG3-NH2 (Sodium salt) | 25mg | 80971 |
elicityl-oligotech | GLY036-1-OPR | Blood group A antigen pentaose type 1-β-O-Propargyl | 25mg | 76015.5 |
elicityl-oligotech | GLY037-1-NPR | Blood group A antigen hexaose type 1-β-NAc-propargyl | 25mg | 76015.5 |
elicityl-oligotech | GLY040-1-NAc-sp1-NH2 | Blood group B antigen hexaose type 1-NAc-CH2-(1.4-Tz)-(CH2)2-EG3-NH2 | 25mg | 76015.5 |
elicityl-oligotech | GLY040-1-NAc-sp2-NH2 | Blood group B antigen hexaose type 1-NAc-CH2-(1.4-Tz)-(CH2)2-EG7-NH2 | 25mg | 76015.5 |
elicityl-oligotech | GLY040-1-NPR | Blood group B antigen hexaose type 1-β-NAc-propargyl | 25mg | 76015.5 |
elicityl-oligotech | GLY050-NAc-sp1-NH2 | Lewis X tetraose-NAc-CH2-(1.4-Tz)-(CH2)2-EG3-NH2 | 25mg | 76015.5 |
elicityl-oligotech | GLY050-OPR | Lewis x tetraose-β-O-propargyl | 25mg | 76015.5 |
elicityl-oligotech | GLY052-NPR | Lewis y pentaose-NAc-propargyl | 25mg | 76015.5 |
elicityl-oligotech | GLY052-NAc-sp1-NH2 | Lewis y pentaose-NAc-CH2-(1.4-Tz)-(CH2)2-EG3-NH2 | 25mg | 76015.5 |
elicityl-oligotech | GLY053-OPR | Sialyl Lewis x pentaose-β-O-propargyl - Sodium salt | 25mg | 76015.5 |
elicityl-oligotech | GLY054-NAc-sp1-NH2 | Lewis a tetraose-NAc-CH2-(1.4-Tz)-(CH2)2-EG3-NH2 | 25mg | 76015.5 |
elicityl-oligotech | GLY056-NPR | Lewis b pentaose-N-acetyl-propargyl | 25mg | 76015.5 |
elicityl-oligotech | GLY123-NPR | Globo-H-β-NAc-propargyl / SSEA3b-β-NAc-propargyl | 25mg | 76015.5 |
elicityl-oligotech | ALG530 | Mannuronate oligosaccharides DP3 (sodium salt) | 1000mg | 76109 |
elicityl-oligotech | GLY230-90% | 2’FucosylLactulose / 2’FLactulose | 100mg | 76109 |
elicityl-oligotech | GLY123-NAc-sp1-NH2-98% | Globo-H hexaose (SSEA-3b)-NAc-CH2-(1.4-Tz)-(CH2)2-EG3-NH2 (>98% NMR) | 5mg | 76296 |
elicityl-oligotech | GLY031-3-13C labelled | 2'FL labelled 13C | 250mg | 77137.5 |
elicityl-oligotech | GLY032-2-90% | Blood group H antigen tetraose type 2 (>90% NMR) | 100mg | 78166 |
elicityl-oligotech | GLY074-2-90% | Xeno antigen type 2 / Galili antigen triaose / Galα -3 epitope/Linear B-2 trisaccharide (>90% NMR) | 500mg | 79194.5 |
elicityl-oligotech | ALG330 | Guluronate oligosaccharides average DP3 (sodium salt) | 1000mg | 85365.5 |
elicityl-oligotech | GLY010-90% | Lacto-N-tetraose (LNT) (>90% NMR) | 5000mg | 80877.5 |
elicityl-oligotech | GLY120-NAc-sp1-NH2 | Globotriaose (Gb3)-NAc-CH2-(1.4-Tz)-(CH2)2-EG3-NH2 | 25mg | 80971 |
elicityl-oligotech | GLY031-3-85% | Blood group H antigen triaose type 5 / 2’Fucosyllactose / 2'FL (>85% NMR) | 100g | 81251.5 |
elicityl-oligotech | FRU113-95% | Fructo-oligosaccharide DP7 / GF6 / 1-F-(1-β-fructofuranosyl)-3-nystose (>95% HPAEC-PAD) | 100mg | 82560.5 |
elicityl-oligotech | FRU113-90% | Fructo-oligosaccharide DP7 / GF6 / 1-F-(1-β-fructofuranosyl)-3-nystose (>90% HPAEC-PAD) | 100mg | 82560.5 |
elicityl-oligotech | GLY070-90% | Isoglobotriaose / iGb3 / 3'-Galactosyl-lactose/ linear B-6 trisaccharide (>90% NMR) | 500mg | 84711 |
elicityl-oligotech | GLY070-90% | copy of Isoglobotriaose / iGb3 / 3'-Galactosyl-lactose/ linear B-6 trisaccharide (>90% NMR) | 500mg | 84711 |
elicityl-oligotech | GLY070-90% | copy of Isoglobotriaose / iGb3 / 3'-Galactosyl-lactose/ linear B-6 trisaccharide (>90% NMR) | 500mg | 84711 |
elicityl-oligotech | GLY011-95% | Lacto-N-Triaose (LNT2) (>95% HPLC) | 250mg | 85365.5 |
elicityl-oligotech | GLY074-2-95% | Xeno antigen type 2 / Galili antigen triaose / Galα -3 epitope/Linear B-2 trisaccharide (>95% NMR) | 500mg | 85365.5 |
elicityl-oligotech | FRU112-95% | Fructo-oligosaccharide DP6 / GF5 / 1-F-(1-β-fructofuranosyl)-2-nystose (>95% HPAEC-PAD) | 100mg | 86300.5 |
elicityl-oligotech | GLY079-BSA | Galili antigen undecaose linked to BSA | 5mg | 86394 |
elicityl-oligotech | GLY010-95% | Lacto-N-tetraose (LNT) (>95% HPLC) | 5000mg | 87329 |
elicityl-oligotech | GLY163-90% | 2'2 Difucosyllactose (>90% NMR) | 100mg | 87422.5 |
elicityl-oligotech | GLY061-90% | Lacto-N-neofucopentaose / LNnFP-V/LNFP VI | 100mg | 87703 |
elicityl-oligotech | GLU601 | Isolichenan polysaccharide | 10000mg | 88077 |
elicityl-oligotech | FRU114-90% | Fructo-oligosaccharide DP8 / GF7 (>90% HPAEC-PAD) | 100mg | 89105.5 |
elicityl-oligotech | FRU114-95% | Fructo-oligosaccharide DP8 / GF7 (>95% HPAEC-PAD) | 100mg | 89105.5 |
elicityl-oligotech | GLY070-95% | Isoglobotriaose / iGb3 / 3'-Galactosyl-lactose/ linear B-6 trisaccharide (>95% NMR) | 500mg | 90695 |
elicityl-oligotech | GLU1161 | Reduced XLFG xyloglucan oligosaccharide (DP10) XLFGol | 1000mg | 91256 |
elicityl-oligotech | GLY096-OAP | GM1a Ganglioside oligosaccharide-β-aminopropyl (>90%) (Sodium salt) | 50mg | 97707.5 |
elicityl-oligotech | LEC402 | Langerin ECD (extra-cellular domain) - (Human protein produced in E. coli) | 1mg | 94715.5 |
elicityl-oligotech | XYL101 | Glucurono-Arabinoxylan PLS from wheat bran | 10000mg | 94715.5 |
elicityl-oligotech | GLY070-98% | Isoglobotriaose / iGb3 / 3'-Galactosyl-lactose/ linear B-6 trisaccharide (>98% NMR) | 500mg | 96492 |
elicityl-oligotech | GLY031-3-13C labelled | 2'FL labelled 13C | 500mg | 96679 |
elicityl-oligotech | GLY094-NAc-sp3-DBt | GD2 Ganglioside oligosaccharide - Desthiobiotin | 5mg | 105561.5 |
elicityl-oligotech | GLU310 | Maltodextrin High DP10-40 oligosaccharide mixture | 10000mg | 98736 |
elicityl-oligotech | GLU311 | Maltodextrin oligosaccharide mixture | 10000mg | 98736 |
elicityl-oligotech | GLY031-3-90% | Blood group H antigen triaose type 5 / 2’Fucosyllactose / 2'FL (>90% NMR) | 5000mg | 99203.5 |
elicityl-oligotech | GLY096-80% | GM1a Ganglioside oligosaccharide (>80%) (Sodium salt) | 1000mg | 107151 |
elicityl-oligotech | FRU115-90% | Fructo-oligosaccharide DP9 / GF8 (>90% HPAEC-PAD) | 100mg | 102008.5 |
elicityl-oligotech | FRU115-95% | Fructo-oligosaccharide DP9 / GF8 (>95% HPAEC-PAD) | 100mg | 102008.5 |
elicityl-oligotech | ALG300 | Guluronate oligosaccharides average DP20 (sodium salt) | 10000mg | 111919.5 |
elicityl-oligotech | FRU116-95% | Fructo-oligosaccharide DP10 / GF9 (>95% HPAEC-PAD) | 100mg | 105000.5 |
elicityl-oligotech | GLY031-3-95% | Blood group H antigen triaose type 5 / 2’Fucosyllactose / 2'FL (>95% NMR) | 5000mg | 107151 |
elicityl-oligotech | ALG542 | Manuronate oligosaccharide DP2 (sodium salt) | 1000mg | 109021 |
elicityl-oligotech | ALG543 | Manuronate oligosaccharide DP3 (sodium salt) | 1000mg | 109021 |
elicityl-oligotech | ALG544 | Manuronate oligosaccharide DP4 (sodium salt) | 1000mg | 109021 |
elicityl-oligotech | ALG500 | Mannuronate oligosaccharides Average DP20 (sodium salt) | 10000mg | 117249 |
elicityl-oligotech | GLY066-90% | Lactodifucotetraose / Difucosyllactose / DF-L (>90% NMR) | 100mg | 111078 |
elicityl-oligotech | GLY033-1-90% | Blood group H antigen pentaose type 1 / Lacto-N-fucopentaose I (LNFP I) (>90% NMR) | 1000mg | 114070 |
elicityl-oligotech | GLY131-90% | SSEA-4 hexaose / Stage-Specific Embryonic Antigen-4 hexaose (>90% NMR) | 100mg | 116220.5 |
elicityl-oligotech | GLY157-90% | 3 Sialylgalactose - GM4 (>90% NMR) | 1000mg | 117062 |
elicityl-oligotech | GLY070-90% | Isoglobotriaose / iGb3 / 3'-Galactosyl-lactose/ linear B-6 trisaccharide (>90% NMR) | 1000mg | 120334.5 |
elicityl-oligotech | GLY070-90% | copy of Isoglobotriaose / iGb3 / 3'-Galactosyl-lactose/ linear B-6 trisaccharide (>90% NMR) | 1000mg | 120334.5 |
elicityl-oligotech | GLY070-90% | copy of Isoglobotriaose / iGb3 / 3'-Galactosyl-lactose/ linear B-6 trisaccharide (>90% NMR) | 1000mg | 120334.5 |
elicityl-oligotech | GLY096-90% | GM1a Ganglioside oligosaccharide (>90%) (Sodium salt) | 1000mg | 132676.5 |
elicityl-oligotech | GLY060-90% | 3 Fucosyllactose / 3-FL (>90% NMR) | 5000mg | 124729 |
elicityl-oligotech | GLY066-90% | Lactodifucotetraose / Difucosyllactose / DF-L (>90% NMR) | 250mg | 128188.5 |
elicityl-oligotech | GLY070-95% | Isoglobotriaose / iGb3 / 3'-Galactosyl-lactose/ linear B-6 trisaccharide (>95% NMR) | 1000mg | 128562.5 |
elicityl-oligotech | GLY153-90% | α1-3 galactobiose / Galα1-3Gal (>90% NMR) | 1000mg | 129217 |
elicityl-oligotech | GLU1110 | XFG xyloglucan oligosaccharide (DP7) | 1000mg | 129591 |
elicityl-oligotech | GLY022-90% | Para-Lacto-N-neohexaose (Para-LNnH) (>90% NMR) | 1000mg | 129591 |
elicityl-oligotech | GLY154-90% | α1-4 galactobiose / Galα1-4Gal (>90% NMR) | 500mg | 131554.5 |
elicityl-oligotech | GLY031-3-98% | Blood group H antigen triaose type 5 / 2’Fucosyllactose / 2'FL (>98% HPLC) | 5000mg | 131741.5 |
elicityl-oligotech | GLY031-3-13C labelled | 2'FL labelled 13C | 1000mg | 132022 |
elicityl-oligotech | GLY066-95% | Lactodifucotetraose / Difucosyllactose / DF-L (>95% NMR) | 100mg | 133331 |
elicityl-oligotech | GLY096-95% | GM1a Ganglioside oligosaccharide (>95%) (Sodium salt) | 1000mg | 146047 |
elicityl-oligotech | GLY070-98% | Isoglobotriaose / iGb3 / 3'-Galactosyl-lactose/ linear B-6 trisaccharide (>98% NMR) | 1000mg | 136790.5 |
elicityl-oligotech | GLY010-90% | Lacto-N-tetraose (LNT) (>90% NMR) | 10000mg | 137445 |
elicityl-oligotech | GLY010-95% | Lacto-N-tetraose (LNT) (>95% HPLC) | 10000mg | 144270.5 |
elicityl-oligotech | GLY094-NAc-sp3-DBt | GD2 Ganglioside oligosaccharide - Desthiobiotin | 10mg | 157360.5 |
elicityl-oligotech | GLY031-3-99% | Blood group H antigen triaose type 5 / 2’Fucosyllactose / 2'FL (>99% HPLC) | 5000mg | 147449.5 |
elicityl-oligotech | GLY021-90% | Lacto-N-neotetraose (LNnT / neo-LNT) | 5000mg | 149132.5 |
elicityl-oligotech | GLY066-95% | Lactodifucotetraose / Difucosyllactose / DF-L (>95% NMR) | 250mg | 152218 |
elicityl-oligotech | GLY074-2-90% | Xeno antigen type 2 / Galili antigen triaose / Galα -3 epitope/Linear B-2 trisaccharide (>90% NMR) | 1000mg | 155303.5 |
elicityl-oligotech | GLY097-90% | GM1b Ganglioside oligosaccharide (>90%) (Sodium salt) | 5000mg | 166617 |
elicityl-oligotech | GLY021-95% | Lacto-N-neotetraose (LNnT / neo-LNT) (>95% HPLC) | 5000mg | 156612.5 |
elicityl-oligotech | GLY023-90% | Lacto-N-neooctaose (LNnO) (>90%) | 100mg | 157360.5 |
elicityl-oligotech | GLY034-90% | Blood group A antigen triaose | 1000mg | 161474.5 |
elicityl-oligotech | GLY023-95% | Lacto-N-neooctaose (LNnO) (>95% HPLC) | 100mg | 165214.5 |
elicityl-oligotech | GLY081-85% | LS-Tetrasaccharide a (LSTa) / Sialyl-lacto-N-tetraose a (>85% NMR) (Sodium salt) | 500mg | 165775.5 |
elicityl-oligotech | GLY055-90% | Lewis a (Le a) hexaose / Lacto-N-difucohexaose II (LNDFH II) (>90% NMR) | 1000mg | 166617 |
elicityl-oligotech | GLY096-OAP | GM1a Ganglioside oligosaccharide-β-aminopropyl (>90%) (Sodium salt) | 100mg | 181016 |
elicityl-oligotech | GLY066-90% | Lactodifucotetraose / Difucosyllactose / DF-L (>90% NMR) | 500mg | 171759.5 |
elicityl-oligotech | GLY035-2-90% | Blood group A antigen tetraose type 2 | 1000mg | 172788 |
elicityl-oligotech | GLY023-98% | Lacto-N-neooctaose (LNnO) (>98% HPLC) | 100mg | 173536 |
elicityl-oligotech | REF066 | Difucosyllactose (DF-L) Analytical Reference | 50mg | 174845 |
elicityl-oligotech | GLY094-90% | GD2 Ganglioside oligosaccharide (>90%) (Sodium salt) | 100mg | 189244 |
elicityl-oligotech | GLY037-1-90% | Blood group A antigen hexaose type 1 (>90% NMR) | 1000mg | 185130 |
elicityl-oligotech | ULV102 | Ulvan polysaccharides from Ulva sp. Fine grade | 10000mg | 189244 |
elicityl-oligotech | GLY154-90% | α1-4 galactobiose / Galα1-4Gal (>90% NMR) | 1000mg | 190272.5 |
elicityl-oligotech | GLY081-90% | LS-Tetrasaccharide a (LSTa) / Sialyl-lacto-N-tetraose a (>90% NMR) (Sodium salt) | 500mg | 193919 |
elicityl-oligotech | GLY094-95% | GD2 Ganglioside oligosaccharide (>95%) (Sodium salt) | 100mg | 208131 |
elicityl-oligotech | GLY077-90% | Galili antigen heptaose (>90% NMR) | 100mg | 196817.5 |
elicityl-oligotech | GLY077-95% | Galili antigen heptaose (>95% NMR) | 100mg | 196817.5 |
elicityl-oligotech | ULV006 | Ulvan oligosaccharides (Cut-off: between 1 & 3kDa ) from Enteromorpha sp. | 1000mg | 199342 |
elicityl-oligotech | GLY066-95% | Lactodifucotetraose / Difucosyllactose / DF-L (>95% NMR) | 500mg | 204671.5 |
elicityl-oligotech | HGL101 | Sulfated heteropolysaccharides fine grade | 1000mg | 205700 |
elicityl-oligotech | GLY078-85% | Galili antigen nonaose (>85% NMR) | 100mg | 207757 |
elicityl-oligotech | GLY078-90% | Galili antigen nonaose (>90% NMR) | 100mg | 216546 |
elicityl-oligotech | GLY066-90% | Lactodifucotetraose / Difucosyllactose / DF-L (>90% NMR) | 1000mg | 228327 |
elicityl-oligotech | GLY094-NAc-sp3-Bt | GD2 Ganglioside oligosaccharide - Biotin | 5mg | 246840 |
elicityl-oligotech | GLY123-90% | Globo-H hexaose / Stage Specific Embryonic Antigen 3b (SSEA-3b) (>90% NMR) | 1000mg | 234498 |
elicityl-oligotech | GLY031-3-99% | Blood group H antigen triaose type 5 / 2’Fucosyllactose / 2'FL (>99% HPLC) | 10000mg | 236555 |
elicityl-oligotech | GLY035-3-90% | Blood group A antigen tetraose type 5 (>90% NMR) | 1000mg | 263857 |
elicityl-oligotech | MAN800 | Mannan polysaccharide (Ivory Nut or Tagua) - 1.4-beta-D-Mannan | 100g | 266101 |
elicityl-oligotech | GLY066-95% | Lactodifucotetraose / Difucosyllactose / DF-L (>95% NMR) | 1000mg | 269467 |
elicityl-oligotech | GLY091-90% | GD3 Ganglioside oligosaccharide / Disialyl lactose/ DS-L (>90%) (Sodium salt) | 1000mg | 293122.5 |
elicityl-oligotech | GLY022-90% | Para-Lacto-N-neohexaose (Para-LNnH) (>90% NMR) | 5000mg | 282463.5 |
elicityl-oligotech | GLY033-1-90% | Blood group H antigen pentaose type 1 / Lacto-N-fucopentaose I (LNFP I) (>90% NMR) | 5000mg | 286951.5 |
elicityl-oligotech | GLY181-90% | Glucuronyl-LNT / Glucuronyl-Lacto-N-tetraose (>90% NMR) (Sodium salt) | 1000mg | 293122.5 |
elicityl-oligotech | GLY038-2-90% | Blood group B antigen tetraose type 2 (>90% NMR) | 1000mg | 296208 |
elicityl-oligotech | GLY081-90% | LS-Tetrasaccharide a (LSTa) / Sialyl-lacto-N-tetraose a (>90% NMR) (Sodium salt) | 1000mg | 329494 |
elicityl-oligotech | GLY051-75% | Lewis x (LeX) hexaose / Lacto-N-neodifucohexaose (LNnDFH) (>75% NMR) | 1000mg | 361097 |
elicityl-oligotech | GLY051-90% | Lewis x (LeX) hexaose / Lacto-N-neodifucohexaose (LNnDFH) (>90% NMR) | 1000mg | 361097 |
elicityl-oligotech | GLY063 | 3’Sialyl-3Fucosyllactose / F-SL (Sodium salt) | 1000mg | 376711.5 |
elicityl-oligotech | GLY031-3-13C labelled | 2'FL labelled 13C | 5000mg | 396907.5 |
elicityl-oligotech | LEC401 | DC-SIGN ECD (extra-cellular domain) - (Human protein produced in E. coli) | 10mg | 456186.5 |
elicityl-oligotech | LEC402 | Langerin ECD (extra-cellular domain) - (Human protein produced in E. coli) | 10mg | 494147.5 |
elicityl-oligotech | GLY061-90% | Lacto-N-neofucopentaose / LNnFP-V/LNFP VI | 1000mg | 543048 |
elicityl-oligotech | GLY035-2-90% | Blood group A antigen tetraose type 2 | 5000mg | 617100 |
elicityl-oligotech | GLY055-90% | Lewis a (Le a) hexaose / Lacto-N-difucohexaose II (LNDFH II) (>90% NMR) | 5000mg | 624767 |
elicityl-oligotech | GLY037-1-90% | Blood group A antigen hexaose type 1 (>90% NMR) | 5000mg | 694331 |
elicityl-oligotech | GLY094-90% | GD2 Ganglioside oligosaccharide (>90%) (Sodium salt) | 1000mg | 791945 |
elicityl-oligotech | GLY023-90% | Lacto-N-neooctaose (LNnO) (>90%) | 1000mg | 786896 |
elicityl-oligotech | GLY023-95% | Lacto-N-neooctaose (LNnO) (>95% HPLC) | 1000mg | 786896 |
elicityl-oligotech | GLY023-98% | Lacto-N-neooctaose (LNnO) (>98% HPLC) | 1000mg | 786896 |
elicityl-oligotech | GLY035-3-90% | Blood group A antigen tetraose type 5 (>90% NMR) | 5000mg | 989323.5 |
elicityl-oligotech | GLY038-2-90% | Blood group B antigen tetraose type 2 (>90% NMR) | 5000mg | 1049070 |
elicityl-oligotech | GLY051-75% | Lewis x (LeX) hexaose / Lacto-N-neodifucohexaose (LNnDFH) (>75% NMR) | 5000mg | 1353693 |
elicityl-oligotech | GLY051-90% | Lewis x (LeX) hexaose / Lacto-N-neodifucohexaose (LNnDFH) (>90% NMR) | 5000mg | 1353693 |
elicityl-oligotech | GLY063 | 3’Sialyl-3Fucosyllactose / F-SL (Sodium salt) | 5000mg | 1412130.5 |
elicityl-oligotech | GLY062-80% | Lacto-N-fucopentaose V / LNFP V (>80% NMR) | 5000mg | 1550417 |
elicityl-oligotech | GLY061-90% | Lacto-N-neofucopentaose / LNnFP-V/LNFP VI | 5000mg | 2036430 |
elicityl-oligotech | GLY023-90% | Lacto-N-neooctaose (LNnO) (>90%) | 5000mg | 2950486 |
elicityl-oligotech | GLY023-95% | Lacto-N-neooctaose (LNnO) (>95% HPLC) | 5000mg | 2950486 |
elicityl-oligotech | GLY023-98% | Lacto-N-neooctaose (LNnO) (>98% HPLC) | 5000mg | 2950486 |
elicityl-oligotech | GLU429 | Chitosan oligosaccharide kit - 5x10 mg DP 6 to 60 | 5x10mg | 询价 |
elicityl-oligotech | GLU700 | Scleroglucan polysaccharide | 250g | 询价 |
elicityl-oligotech | GLY033-1-NAc-sp3-Bt | Blood group H antigen pentaose type 1-NAc-CH2-(1.4-Tz)-(CH2)2-EG3-NH-Biotin | 5mg | 询价 |
elicityl-oligotech | GLY034-OAP | Blood group A antigen triaose-β-O-aminopropyl | 100mg | 询价 |
elicityl-oligotech | GLY034-OAP | Blood group A antigen triaose-β-O-aminopropyl | 500mg | 询价 |
elicityl-oligotech | GLY034-OAP | Blood group A antigen triaose-β-O-aminopropyl | 1000mg | 询价 |
elicityl-oligotech | GLY037-1-NAc-Sp3-Bt | Blood group A antigen hexaose type 1-NAc-CH2-(1.4-Tz)-(CH2)2-EG3-NH-Biotin | 5mg | 询价 |
elicityl-oligotech | GLY040-1-NAc-sp3-Bt | Blood group B antigen hexaose type 1-NAc-CH2-(1.4-Tz)-(CH2)2-EG3-NH-Biotin | 5mg | 询价 |
elicityl-oligotech | GLY052-NAc-sp3-Bt | Lewis y (LeY) pentaose-NAc-CH2-(1.4-Tz)-(CH2)2-EG3-NH-Biotin | 5mg | 询价 |
elicityl-oligotech | GLY056-NAc-sp3-Bt | Lewis b (Le b) pentaose-O-CH2-(1.4-Tz)-(CH2)2-EG3-NH-Biotin | 5mg | 询价 |
elicityl-oligotech | GLY058-AP | Blood group B antigen triaose-β-O-aminopropyl | 100mg | 询价 |
elicityl-oligotech | GLY058-AP | Blood group B antigen triaose-β-O-aminopropyl | 500mg | 询价 |
elicityl-oligotech | GLY058-AP | Blood group B antigen triaose-β-O-aminopropyl | 1000mg | 询价 |
elicityl-oligotech | GLY083-KLH | LS-Tetrasaccharide d (LSTd) linked to KHL | 0 | 询价 |
elicityl-oligotech | GLY103-NAc-sp3-Bt | Fucosyl GM1 Ganglioside oligosaccharide - Biotin | 5mg | 询价 |
elicityl-oligotech | GLY120-NAc-sp3-Bt | Globotriaose (Gb3)-NAc-CH2-(1.4-Tz)-(CH2)2-EG3-NH-Biotin | 5mg | 询价 |
elicityl-oligotech | GLY121-NAc-sp3-Bt | Globotetraose (Gb4)-Biotin | 5mg | 询价 |
elicityl-oligotech | GLY122-NAc-sp3-Bt | Globopentaose (Gb5)-Biotin | 5mg | 询价 |
elicityl-oligotech | GLY123-NAc-sp3-Bt | Globo-H-Biotin | 5mg | 询价 |
elicityl-oligotech | GLY124-NAc-sp3-Bt | Globo-A heptaose-Biotin | 5mg | 询价 |
elicityl-oligotech | GLY125-NAc-sp3-Bt | Globo-B heptaose-Biotin | 5mg | 询价 |
elicityl-oligotech | GLY131-NAc-sp3-Bt | SSEA-4 hexaose-Biotin | 5mg | 询价 |
elicityl-oligotech | XXXXXX | Produit formation | 1mg | 询价 |
elicityl-oligotech | XXXXXX | Produit formation | 25mg | 询价 |
elicityl-oligotech | XXXXXX | Produit formation | 100g | 询价 |
elicityl-oligotech | GLY035-3-O-S-NH2-97% | Blood group A antigen tetraose type 5-O-S-NH2 (>97% NMR) | 2000mg | 询价 |
elicityl-oligotech | GLY038-3-O-S-NH2-97% | Blood group B antigen tetraose type 5-O-S-NH2 (>97% NMR) | 2000mg | 询价 |
elicityl-oligotech | BAR038-3-O-S-NH2 | Blood group B antigen tetraose type 5-O-S-NH2 (>97% HPLC) | 5000mg | 询价 |
elicityl-oligotech | BAR038-3-O-S-NH2 | Blood group B antigen tetraose type 5-O-S-NH2 (>97% HPLC) | 10000mg | 询价 |
elicityl-oligotech | BAR035-3-O-S-NH2 | Blood group A antigen tetraose type 5-O-S-NH2 (>97% HPLC) | 5000mg | 询价 |
elicityl-oligotech | BAR035-3-O-S-NH2 | Blood group A antigen tetraose type 5-O-S-NH2 (>97% HPLC) | 10000mg | 询价 |
无锡药科美生物科技有限公司专业从事生命科学行业前沿技术服务与产品进出口服务,欢迎订购咨询全球各国各种进口产品。